"title","doi","altmetric_jid","score","X1d","X3d","X1w","X1m","authors","author_corresponding","author_corresponding_institution","date","version","type","license","category","jatsxml","abstract","published","server","upupdate_time"
"Estimating the lives that could be saved by expanded access to weight-loss drugs","10.1101/2024.06.27.24309551","medrxiv",69,66,68.5,68.5,68.5,"Pandey, A.; Ye, Y.; Wells, C. R.; Singer, B. H.; Galvani, A. P.","Alison P Galvani","Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA","2024-06-28","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","health policy","https://www.medrxiv.org/content/early/2024/06/28/2024.06.27.24309551.source.xml","Obesity is a major public health crisis in the United States (US) affecting 42% of the population, exacerbating a spectrum of other diseases and contributing significantly to morbidity and mortality overall. Recent advances in pharmaceutical interventions, particularly glucagon-like peptide-1 (GLP-1) receptor agonists (e.g., semaglutide, liraglutide) and dual gastric inhibitory polypeptide and glucagon-like peptide-1 (GIP/GLP-1) receptor agonists (e.g., tirzepatide), have shown remarkable efficacy in weight loss. However, limited access to these medications due to high costs and insurance coverage issues restricts their utility in mitigating the obesity epidemic. We quantify the annual mortality burden directly attributable to limited access to these medications in the US. By integrating hazard ratios of mortality across body mass index categories with current obesity prevalence data, combined with willingness to take the medication, observed adherence to and efficacy of the medications, we estimate the impact of making these medications accessible to all those eligible. Specifically, we project that with expanded access, over 43,000 deaths could be averted annually, including more than 12,000 deaths among people with type 2 diabetes. These findings underscore the urgent need to address barriers to access and highlight the transformative public health impact that could be achieved by expanding access to these novel treatments.","NA","medrxiv",1727302158081
"Preventive interventions for post Covid-19 condition: systematic review update","10.1101/2024.09.18.24313918","medrxiv",60.80000000000001,50.500000000000014,60.80000000000001,60.80000000000001,60.80000000000001,"Pillay, J.; Rahman, S.; Gehring, N.; Guitard, S.; Ashiq, A. R.; Hartling, L.","Jennifer Pillay","University of Alberta","2024-09-23","1","PUBLISHAHEADOFPRINT","cc_by_nc","infectious diseases","https://www.medrxiv.org/content/early/2024/09/23/2024.09.18.24313918.source.xml","Background: Post COVID-19 condition (PCC) can affect individuals regardless of the severity of their initial illness, and its impact on daily life can be significant. There are uncertainties about whether treatments in the acute or post-acute phase of infection can prevent PCC. We report an update to a previous systematic review on the effects of interventions to prevent PCC. Methods: We updated our previous peer-reviewed searches on February 9, 2024. We searched bibliographic databases and grey literature resources to identify trials and comparative observational studies reporting on any intervention provided during the acute (symptom onset to 4 weeks) or post-acute phase (4-8 weeks) of COVID-19 and our primary outcome of incidence of PCC, ascertained at 3 months or longer following infection and capturing, at a minimum, symptoms of fatigue, dyspnea and one or more aspects of cognitive function. Non-recovery from COVID-19 was included if necessary. Secondary outcomes included fatigue, breathlessness/dyspnea, post-exertional malaise, health-related quality of life, psychopathology, cognitive impairment, hospitalization, return to work/education, and adverse effects of the intervention. For screening we employed artificial intelligence to prioritize records and modified our methods to rely on single-reviewer screening after 50% of citations were screened in duplicate. Study selection and risk of bias assessments were conducted independently by two reviewers and data extraction relied on verification of another reviewers work. We grouped studies by intervention type and timing, and by acute-care setting, and performed meta-analysis where appropriate. Sensitivity analyses were conducted for the primary outcome, excluding studies with high risk of bias, using non-recovery as a proxy outcome, and evaluating the outcome at more than 12 months of follow-up. We assessed the certainty of evidence using GRADE. Results: Twenty-four studies (5 randomized and 19 non-randomized), all among adults, were included. The acute care setting in nine studies was outpatient and in 15 studies was in-patient; all but one intervention was administered during the acute-phase of illness. The use of convalescent plasma in outpatient acute COVID-19 care probably does not reduce the risk of PCC (relative risk [RR]: 0.93, 95% CI: 0.77-1.12; 1 RCT; moderate certainty). There was low-certainty evidence suggesting that probiotics (RR [95% CI]: 0.32 [0.13-0.78]; 1 RCT) and metformin (0.50 [0.25-0.99]; 1 RCT among individuals with a BMI >=25 kg/m2) reduce PCC to a small-to-moderate extent in outpatients, while ivermectin (outpatients), antivirals (outpatients), steroids (in-patients), and therapeutic-dose heparin (vs. prophylactic dose; in-patients) may not be effective. Evidence was very low certainty for several other acute-phase pharmacologic intervention and post-acute outpatient assessment and referrals. For outpatient antiviral treatment, while overall PCC risk may not decrease, there might be a slight reduction in psychopathology. Similarly, inpatient antiviral use may not prevent PCC but may offer a small reduction in prolonged general malaise after light exertion. Therapeutic-dose heparin may slightly reduce the risk of cognitive impairment compared to prophylactic-dose heparin among in-patients. The findings remained consistent across all these sensitivity analyses. Conclusions: Evidence suggests that PCC can be prevented to some extent among outpatients with the use of probiotics and metformin during the acute phase of COVID-19. Effects from interventions used among in-patients and within the post-acute phase are uncertain at this time. Evidence on commonly recommended interventions including rehabilitation or multidisciplinary care was lacking. Protocol registration: CRD42024513247","NA","medrxiv",1727302158081
"Dance displays in gibbons: Biological and linguistic perspectives on structured, intentional and rhythmic body movement","10.1101/2024.08.29.610299","biorxiv",25.5,15,22.25,22.25,25.5,"Coye, C.; Caspar, K. R.; Patel-Grosz, P.","Kai R Caspar","Institute for Cell Biology, Heinrich Heine University, Duesseldorf, Duesseldorf, Germany","2024-08-30","1","new results","cc_by_nc","animal behavior and cognition","https://www.biorxiv.org/content/early/2024/08/30/2024.08.29.610299.source.xml","Female crested gibbons perform conspicuous sequences of twitching movements involving the rump and extremities. However, these dances have attracted little scientific attention and their structure and meaning remain largely obscure. Here we analyse close-range video recordings of captive crested gibbons, extracting descriptions of dance in four Nomascus species (N. annamensis, N. gabriellae, N. leucogenys, and N. siki). Additionally, we report results from a survey amongst relevant professionals clarifying behavioural contexts of dance in captive and wild crested gibbons. Our results demonstrate that dances in Nomascus represent a common and intentional form of visual communication restricted to sexually mature females. While primarily used as a proceptive signal to solicit copulation, dances occur in a wide range of contexts related to arousal and/or frustration in captivity. A linguistically informed view of this sequential behaviour demonstrates that dances follow a grouping organisation and isochronous rhythm - patterns not described for visual displays in other non-human primates. We argue that applying the concept of dance to gibbons allows us to expand our understanding of the communicative behaviours of non-human apes and develop hypotheses on the rules and regularities characterizing this behaviour. We propose that gibbons dances likely evolved from less elaborate rhythmic proceptive signals, similar to those found in siamangs. Although dance displays in humans and crested gibbons share a number of key characteristics, they cannot be assumed to be homologous. Nevertheless, gibbon dances represent a model behaviour whose investigation could be extended to the study of complex gestural signals in hominoid primates.","NA","biorxiv",1727302158081
"Epigenetic age acceleration and mortality risk prediction in U.S. adults","10.1101/2024.08.21.24312373","medrxiv",16.108,14.858,14.858,14.858,15.108,"Mendy, A.; Mersha, T.","Angelico Mendy","University of Cincinnati","2024-08-29","2","PUBLISHAHEADOFPRINT","cc_by","epidemiology","https://www.medrxiv.org/content/early/2024/08/29/2024.08.21.24312373.source.xml","BackgroundEpigenetic clocks have emerged as novel measures of biological age and potential predictors of mortality. We aimed to test whether epigenetic age acceleration (EAA) estimated using different epigenetic clocks predict long-term overall, cardiovascular or cancer mortality.

MethodsWe analyzed data from 2,105 participants to the 1999-2002 National Health and Nutrition Examination Survey aged [&ge;]50 years old who were followed for mortality through 2019. EAAs was calculated from the residuals of Horvath, Hannum, SkinBlood, Pheno, Zhang, Lin, Weidner, Vidal-Bralo and Grim epigenetic clocks regressed on chronological age. Using cox proportional hazards regression, we estimated the hazard ratio (HR) and 95% confidence interval (CI) for the association of EAA (per 5-year) and the DunedinPoAm pace of aging (per 10% increase) with overall, cardiovascular and cancer mortality, adjusting for covariates and white blood cell composition.

ResultsDuring a median follow-up of 17.5 years, 998 deaths occurred, including 272 from cardiovascular disease and 209 from cancer. Overall mortality was most significantly predicted by Grim EAA (P < 0.0001; HR: 1.50, 95% CI: 1.32-1.71) followed by Hannum (P = 0.001; HR: 1.16, 95% CI: 1.07-1.27), Pheno (P = 0.001; HR: 1.13, 95% CI: 1.05-1.21), Horvath (P = 0.007; HR: 1.13, 95% CI: 1.04-1.22) and Vidal-Bralo (P = 0.008; HR: 1.13, 95% CI: 1.03-1.23) EAAs. Grim EAA predicted cardiovascular mortality (P < 0.0001; HR: 1.55, 95% CI: 1.29-1.86), whereas Hannum (P = 0.006; HR: 1.24, 95% CI: 1.07-1.44), Horvath (P = 0.02; HR: 1.18, 95% CI: 1.02-1.35) and Grim (P = 0.049; HR: 1.37, 95% CI: 1.00-1.87) EAAs predicted cancer mortality. DunedinPoAm pace of aging was associated with overall (P = 0.003; HR: 1.23, 95% CI: 1.08-1.38) and cardiovascular (P = 0.04; HR: 1.25, 95% CI: 1.01-1.55) mortality.

ConclusionsIn a U.S. representative sample, Horvath, Hannum, Pheno, Vidal-Bralo and Grim EAA all predicted overall mortality but only Grim EAA predicted cardiovascular mortality and Horvath, Hannum or Grim EAA predicted cancer mortality. Pace of aging predicted overall and cardiovascular mortality.","NA","medrxiv",1727302158081
"Safety and efficacy of rapamycin on healthspan metrics after one year: PEARL Trial Results","10.1101/2024.08.21.24312372","medrxiv",56.580000000000005,13.572,14.572,15.572,36.879999999999995,"Harinath, G.; Lee, V.; Nyquist, A.; Moel, M.; Morgan, S. L.; Isman, A.; Zalzala, S.","Stefanie L Morgan","AgelessRx","2024-09-24","4","PUBLISHAHEADOFPRINT","cc_by_nc_nd","geriatric medicine","https://www.medrxiv.org/content/early/2024/09/24/2024.08.21.24312372.source.xml","Rapamycin has been shown to have longevity-enhancing effects in murine models, but clinical data on its gerotherapeutic effects in humans remains limited. We performed a 48-week double-blinded, randomized, and placebo-controlled decentralized study (Participatory Evaluation of Aging with Rapamycin for Longevity [PEARL]; NCT04488601; registration date 2020-07-28) to evaluate the safety and efficacy of rapamycin in mitigating clinical signs of aging in a normative aging cohort. Participants received 5 or 10 mg / week of compounded rapamycin, or placebo for 48 weeks. Safety, adverse events (AEs) and blood biomarkers were collected. Efficacy was assessed using DEXA scan-based measures and standardized surveys assessing quality of life (QoL) and frailty. We did not detect significant differences in safety blood biomarkers, or moderate to severe AEs between the rapamycin treatment groups and placebo after 48 weeks. We detected dose-dependent (10 mg group) and sex-specific improvements in lean tissue mass, pain, social functioning, overall QoL, and overall osteoarthritis score in females, and in bone mineral content in men. Additionally, some individuals receiving rapamycin experienced significant improvements in body composition metrics that were associated with beneficial changes in gut health and lipid metabolism. We conclude that low-dose, intermittent rapamycin administration over the course of 48 weeks is safe and induces sex-specific improvements in multiple aspects of healthspan, with the most robust improvements in lean tissue mass in women taking 10 mg rapamycin/week. Future work will aim to identify biometric signatures of clinical effectiveness to inform personalized treatment strategies that more broadly maximize efficacy and minimize side effects.","NA","medrxiv",1727302158081
"Metabolic mapping of the human solute carrier superfamily","10.1101/2024.09.23.614124","biorxiv",13.2,13.2,13.2,13.2,13.2,"Wiedmer, T.; Teoh, S. T.; Christodoulaki, E.; Wolf, G.; Tian, C.; Sedlyarov, V.; Jarret, A.; Leippe, P.; Frommelt, F.; Ingles-Prieto, A.; Lindinger, S.; Barbosa, B. M. G.; Onstein, S.; Klimek, C.; Garcia Murias, J.; Serrano, I.; Reil, D.; Santacruz, D.; Piotrowski, M.; Noell, S.; Bueschl, C.; Li, H.; Chi, G.; Mereiter, S.; Oliveira, T.; Penninger, J. M.; Sauer, D. B.; Steppan, C. M.; Viollet, C.; Klavins, K.; Hannich, J. T.; Goldmann, U.; Superti-Furga, G.","Giulio Superti-Furga","CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Center for Physiology and Pharmacology, Medical Universit","2024-09-24","1","new results","cc_by","systems biology","https://www.biorxiv.org/content/early/2024/09/24/2024.09.23.614124.source.xml","Solute carrier (SLC) transporters govern most of the chemical exchange across cellular membranes and are integral to metabolic regulation, which in turn is linked to cellular function and identity. Despite their key role, individual functions of the members of the SLC superfamily were not evaluated systematically. We determined the metabolic and transcriptional profiles upon SLC overexpression in knock-out or wild-type isogenic cell backgrounds. Targeted metabolomics provided a fingerprint of 189 intracellular metabolites, while transcriptomics offered insights into cellular programs modulated by SLC expression. Beyond the metabolic profiles of 102 SLCs directly related to their known substrates, we also identified putative substrates or metabolic pathway connections for 71 SLCs without previously annotated bona fide substrates, including SLC45A4 as a new polyamine transporter. By comparing the molecular profiles, we identified functionally related SLC groups, including some with distinct impacts on osmolyte balancing and glycosylation. The assessment of functionally related human genes presented here may serve as a blueprint for other systematic studies of human gene function and supports future investigations into the functional roles of SLCs.","NA","biorxiv",1727302158081
"The global pattern of centenarians highlights deep problems in demography","10.1101/2024.09.06.24313170","medrxiv",111.108,12.608,12.608,24.108,111.108,"Newman, S. J.","Saul Justin Newman","University College London","2024-09-06","1","PUBLISHAHEADOFPRINT","cc_by_nd","public and global health","https://www.medrxiv.org/content/early/2024/09/06/2024.09.06.24313170.source.xml","Accurate age data is fundamental to medicine, social sciences, epidemiology, and good government. However, recent and heavily disputed debates on data quality have raised questions on the accuracy of demographic data at older ages. Here, we catalogue late-life survival patterns of every country in the world from 1970-2021 using comprehensive estimates of old-age populations provided by global governments and curated by the United Nations. Analysis of 236 nations or states across 51 years reveals that late-life survival data is dominated by anomalies at all scales and in all time periods. Life expectancy at age 100 and late-life survival from ages 80 to 100+, which we term centenarian attainment rate, is highest in a seemingly random assortment of states. The top 10  blue zone regions with the best survival to ages 100+ routinely includes Thailand, Kenya and Malawi - respectively now 212th and 202nd in the world for life expectancy, the non-self-governing territory of Western Sahara, and Puerto Rico where birth certificates are so unreliable they were recently declared invalid as a legal document. These anomalous rankings are conserved across long time periods and multiple non-overlapping cohorts, and do not seem to be sampling effects. Instead these patterns suggest a persistent inability, even for nation-states or global organisations, to detect or measure error rates in human age data, with troubling implications for epidemiology, demography, and medicine.","NA","medrxiv",1727302158081
"Respiratory shedding of infectious SARS-CoV-2 Omicron XBB.1.41.1 lineage with increased evolutionary rate among captive white-tailed deer","10.1101/2024.09.24.613938","biorxiv",10.15,10.15,10.15,10.15,10.15,"Ferreira, F. C.; Pervin, T.; Tang, W. C.; Hediger, J.; Thomas, L. F.; Cook, W.; Cherry, M. J.; Neuman, B.; Hamer, G. L.; Hamer, S. A.","Francisco C. Ferreira","Texas AM University","2024-09-25","1","new results","cc_by","microbiology","https://www.biorxiv.org/content/early/2024/09/25/2024.09.24.613938.source.xml","White-tailed deer (Odocoileus virginianus) have high value for research, conservation, agriculture and recreation, and may be important SARS-CoV-2 reservoirs with unknown human health implications. In November 2023, we sampled 15 female deer in a captive facility in central Texas, USA. All individuals had neutralizing antibodies against SARS-CoV-2 and 11 had RT-qPCR-positive respiratory swabs; one also had a positive rectal swab. Six of 11 respiratory swabs yielded infectious virus with replication kinetics of most samples displaying lower growth 24-48 h post infection in vitro when compared to Omicron lineages isolated from humans in Texas in the same period. However, virus growth was similar between groups by 72 h, suggesting no strong attenuation of deer-derived virus. All deer viruses clustered in XBB Omicron clade, with more mutations than expected compared to contemporaneous viruses in humans, suggesting that crossing the species barrier to deer was accompanied by a high substitution rate.","NA","biorxiv",1727302158081
"Assessing Healthy Vaccinee Effect in COVID-19 Vaccine Effectiveness Studies: A National Cohort Study in Qatar","10.1101/2024.07.28.24311115","medrxiv",160.99999999999974,10.099999999999998,158.24999999999977,158.24999999999977,160.74999999999974,"Chemaitelly, H.; Ayoub, H. H.; Coyle, P.; Tang, P.; Hasan, M. R.; YASSINE, H. M.; Althani, A. A.; Al-Kanaani, Z.; Al-Kuwari, E.; Jeremijenko, A.; Kaleeckal, A. H.; Latif, A. N.; Shaik, R. M.; Abdul-Rahim, H. F.; Nasrallah, G.; Al-Kuwari, M. G.; Al-Romaihi, H. E.; Al-Thani, M. H. J.; Al-Khal, A.; Bertollini, R.; Butt, A. A.; Abu-Raddad, L. J.","Laith J. Abu-Raddad","Weill Cornell Medicine-Qatar","2024-09-03","2","PUBLISHAHEADOFPRINT","cc_no","epidemiology","https://www.medrxiv.org/content/early/2024/09/03/2024.07.28.24311115.source.xml","BackgroundThis study investigated the presence of the healthy vaccinee effect--the imbalance in health status between vaccinated and unvaccinated individuals--in two COVID-19 vaccine effectiveness studies involving primary series and booster vaccinations. It also examined the temporal patterns and variability of this effect across different subpopulations by analyzing the association between COVID-19 vaccination and non-COVID-19 mortality in Qatar.

MethodsTwo matched, retrospective cohort studies assessed the incidence of non-COVID-19 death in national cohorts of individuals with a primary series vaccination versus no vaccination (two-dose analysis), and individuals with three-dose (booster) vaccination versus primary series vaccination (three-dose analysis), from January 5, 2021, to April 9, 2024.

ResultsThe adjusted hazard ratio (aHR) for non-COVID-19 death was 0.76 (95% CI: 0.64-0.90) in the two-dose analysis and 0.85 (95% CI: 0.67-1.07) in the three-dose analysis. In the first six months of follow-up in the two-dose analysis, the aHR was 0.35 (95% CI: 0.27-0.46); however, the combined analysis of all subsequent periods showed an aHR of 1.52 (95% CI: 1.19-1.94). In the first six months of follow-up in the three-dose analysis, the aHR was 0.31 (95% CI: 0.20-0.50); however, the combined analysis of all subsequent periods showed an aHR of 1.37 (95% CI: 1.02-1.85). The overall effectiveness of the primary series and third-dose vaccinations against severe, critical, or fatal COVID-19 was 95.9% (95% CI: 94.0-97.1) and 34.1% (95% CI: -46.4-76.7), respectively. Subgroup analyses showed that the healthy vaccinee effect is pronounced among those aged 50 years and older and among those more clinically vulnerable to severe COVID-19.

ConclusionA strong healthy vaccinee effect was observed in the first six months following vaccination. This effect may have stemmed from a lower likelihood of vaccination among seriously ill, end-of-life individuals, and less mobile elderly populations.","NA","medrxiv",1727302158081
"Effects of residue substitutions on the cellular abundance of proteins","10.1101/2024.09.23.614650","biorxiv",8.899999999999999,8.899999999999999,8.899999999999999,8.899999999999999,8.899999999999999,"Schulze, T. K.; Lindorff-Larsen, K.","Kresten Lindorff-Larsen","University of Copenhagen","2024-09-24","1","new results","cc_by_nc_nd","biophysics","https://www.biorxiv.org/content/early/2024/09/24/2024.09.23.614650.source.xml","Multiplexed assays of variant effects (MAVEs) make it possible to measure the functional impact of all possible single amino acid residue substitutions in a protein in a single experiment. Combination of variant effect data from several such experiments provides the opportunity to conduct large-scale analyses of variant effect scores measured across proteins, but can be complicated by variations in the phenotypes that are probed across experiments. Thus, using variant effect datasets obtained with similar MAVE techniques can help reveal general rules governing the effects of amino acid variation for a single molecular phenotype. In this work, we accordingly combined data from six individual variant abundance by massively parallel sequencing (VAMP-seq) experiments and analysed a total of 31,614 variant effect scores reporting solely on the impact of single amino acid residue substitutions on the cellular abundance of proteins. Using our combined variant effect dataset, we derived and analysed a collection of amino acid substitution matrices describing the average impact on cellular abundance of all residue substitution types in different structural environments. We found that the substitution matrices predict the cellular abundance of protein variants with surprisingly high accuracy when given structural information only in the form of whether a residue is buried or exposed. We thus propose our substitution matrix-based predictions as strong baselines for future abundance model development.","NA","biorxiv",1727302158081
"Disparate demographic impacts of the Roman Colonization and the Migration Period in the Iberian Peninsula.","10.1101/2024.09.23.614606","biorxiv",15.949999999999998,7.75,15.949999999999998,15.949999999999998,15.949999999999998,"Carrion, P.; Olalde, I.; Jimenez-Arenas, J. M.; Coromina, N.; Vivo, D.; Verges, J. M.; Costa, A.; Botella, D.; Bustamante-Alvarez, M.; Heras-Mora, J.; Ortega-Ruiz, R.; Chaves, C.; Garcia-Collado, M. I.; Quiros-Castillo, J.; Roig, J.; Suarez-Padilla, J.; Navarro-Luengo, I.; Cuadrado, M. A.; Aguilera, I.; Morera, J.; Catalan, R.; Cerdeno, M. L.; Roig-Perez, J. F.; Diaz-Garcia, M.; Chirosa-Canavate, P.; Piza-Ruiz, T.; Vallejo-Casas, E.; Vidal-Alvarez, S.; Burch, J.; Sagrera, J.; Vivo, J.; Cubo-Cordoba, A.; Martinez-Enamorado, V.; Rengel-Castro, F.; Garcia-Entero, V.; Rodero, A.; Viguera, E.; Rohl","Pablo Carrion","Institut de Biologia Evolutiva, CSIC-Universitat Pompeu Fabra, Barcelona, Spain","2024-09-23","1","new results","cc_no","genomics","https://www.biorxiv.org/content/early/2024/09/23/2024.09.23.614606.source.xml","It has been unclear how the periods of Roman and later Germanic political control shaped the demography of the Iberian Peninsula and how Iberia differs in these respects from other parts of the Roman Empire. We report genome-wide data from 248 ancient individuals from the largely unsampled period 100-800 CE and co-analyze them with previously reported data. In the Roman era, we document profound demographic transformation, with an influx of people with ancestry from the Central and Eastern Mediterranean in all the areas under study and of North Africans, especially in central and southern Iberia. Germanic (Buri, Suebi, Vandals & Visigoths) and Sarmatian (Alans) took over political control beginning in the 5th century, and although we identify individuals with Germanic-associated ancestry at sites with Germanic-style ornaments and observe that such individuals were closely related across large distances as in the case of two siblings separated by 700 km, for Iberia as a whole, we observe high continuity with the previous Hispano-Roman population. The demographic patterns in Iberia contrast sharply with those in Britain, which showed the opposite pattern of little change in the Roman period followed by great change in the Migration period, and also from demographic patterns in the central Mediterranean where both periods were associated with profound transformation, raising broader questions about the forces that precipitated change over this time.","NA","biorxiv",1727302158081
"Cardiac responses to auditory irregularities reveal hierarchical information processing during sleep","10.1101/2024.09.24.614090","biorxiv",7.1499999999999995,7.1499999999999995,7.1499999999999995,7.1499999999999995,7.1499999999999995,"Koroma, M.; Boulakis, P. A.; Raimondo, F. A.; Gialama, V.; Blume, C.; Strauss, M.; Demertzi, A.","Matthieu Koroma","GIGA Research, Cyclotron Research Center","2024-09-24","1","new results","cc_by","neuroscience","https://www.biorxiv.org/content/early/2024/09/24/2024.09.24.614090.source.xml","Our ability to process environmental stimuli varies during sleep. Although much research focused on neural processing, emerging evidence shows that bodily signals may play a key role in understanding high-level sensory processing during sleep. Here, we tested how cardiac responses to the local-global paradigm, a typical oddball task probing the processing of simple (local) and complex (global) sensory irregularities. To do so, we analyzed electrocardiography (ECG) signals in a total of 56 participants from two existing datasets which contained cerebral responses to local auditory irregularities, but which did not analyze the ECG data before. We found that cardiac activity slowed down after global, but not local, auditory irregularities, revealing the presence of global deviance effect in Rapid Eye Movement (REM) sleep. In contrast, cardiac activity was faster after local, but not global, deviants in Non-Rapid Eye Movement (NREM) sleep. Overall, our results demonstrate that cardiac responses to auditory irregularities inform about hierarchical information processing and its variations during sleep beyond cerebral activity. They highlight the embodiment of cognitive function and the value of cardiac signals to understand the variations of sensory processing during sleep.","NA","biorxiv",1727302158081
"Covid-19 vaccination decisions and impacts of vaccine mandates: A cross sectional survey of healthcare workers in Ontario, Canada","10.1101/2024.06.23.24309372","medrxiv",303.95000000000016,7.1,61.00000000000006,136.3999999999997,191.4999999999994,"Chaufan, C.; Hemsing, N.; Moncrieffe, R.","Claudia Chaufan","York University","2024-06-28","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","health policy","https://www.medrxiv.org/content/early/2024/06/28/2024.06.23.24309372.source.xml","BackgroundSince vaccination policies were introduced in the healthcare sector in the province of Ontario, Canada, most establishments implemented vaccination or termination requirements, with most enforcing them to this day. Researchers have shown a strong interest in the perceived problem of vaccine hesitancy among healthcare workers, yet not in their lived experience of the policy or in their views on the policys impact on the quality of patient care in the province.

GoalTo document the experience and views on mandated vaccination of healthcare workers in the province of Ontario, Canada.

MethodsBetween February and March 2024, we conducted a cross-sectional survey of Ontario healthcare workers, recruited through professional contacts, social media, and word-of-mouth.

FindingsMost respondents, most with 16 or more years of professional experience, were unvaccinated, and most had been terminated due to non-compliance with mandates. As well, and regardless of vaccination status, most respondents reported safety concerns with vaccination, yet did not request an exemption due to their experience of high rejection rates by employers. Nevertheless, most unvaccinated workers reported satisfaction with their vaccination choices, although they also reported significant, negative impacts of the policy on their finances, their mental health, their social and personal relationships, and to a lesser degree, their physical health. In contrast, most respondents within the minority of vaccinated respondents reported being dissatisfied with their vaccination decisions, as well as having experienced mild to serious post vaccine adverse events, with about one-quarter within this group reporting having been coerced into taking further doses, under threat of termination, despite these events. Further, a large minority of respondents reported having witnessed underreporting or dismissal by hospital management of adverse events post vaccination among patients, worse treatment of unvaccinated patients, and concerning changes in practice protocols. Close to half also reported their intention to leave the healthcare industry.

DiscussionOur findings indicate that in Ontario, Canada, mandated vaccination in the health sector had an overall negative impact on the well-being of the healthcare labour force, on patient care, on the sustainability of the health system, and on ethical medical practice. Our study should be reproduced in other provinces, as well as in other countries that adopted comparable policies. Findings from this and similar studies should be seriously considered when planning for future health emergencies, to protect health systems in crisis due to severe labour shortages, as well as the right to informed consent of healthcare workers and members of the public.","NA","medrxiv",1727302158081
"Stimulating the regenerative capacity of the human retina with proneural transcription factors in 3D cultures","10.1101/2024.09.24.614778","biorxiv",6.95,6.95,6.95,6.95,6.95,"Wohlschlegel, J.; Kierney, F.; Arakelian, K. L.; Luxardi, G.; Suvarnpradip, N.; Hoffer, D.; Rieke, F.; Moshiri, A.; Reh, T. A.","Thomas A Reh","University of Washington","2024-09-24","1","new results","cc_by_nc_nd","developmental biology","https://www.biorxiv.org/content/early/2024/09/24/2024.09.24.614778.source.xml","Retinal diseases often lead to degeneration of specific retinal cell types with currently limited therapeutic options to replace the lost neurons. Previous studies have reported that overexpression of ASCL1 or combinations of proneural factors in Muller glia (MG) induces regeneration of functional neurons in the adult mouse retina. Recently, we applied the same strategy in dissociated cultures of fetal human MG and although we stimulated neurogenesis from MG, our effect in 2D cultures was modest and our analysis of newborn neurons was limited. In this study, we aimed to improve our MG reprogramming strategy in a more intact retinal environment. For this purpose, we used an in vitro culture system of human fetal retinal tissue and adult human postmortem retina. To stimulate reprogramming, we used lentiviral vectors to deliver constructs with a glial-specific promoter (HES1) driving ASCL1 alone or in combination with additional developmental transcription factors such as ATOH1 and NEUROD1. Combining IHC, scRNA-seq and electrophysiology, we show for the first time that human MG can generate new neurons even in adults. This work constitutes a key step towards a future clinical application of this regenerative medicine approach for retinal degenerative disorders.","NA","biorxiv",1727302158081
"Macrophages redeploy functional cancer cell surface proteins following phagocytosis","10.1101/2024.09.23.613776","biorxiv",6.45,6.45,6.45,6.45,6.45,"Volk, R. F.; Casebeer, S. W.; Condon, A. C.; Zirak, B.; Manon, N.; Irkliyenko, I.; Liao, H.; Tao, S.; Pollini, T.; Ramani, V.; Maker, A.; Fidler, T.; Goodarzi, H.; Zaro, B. W.","Balyn W Zaro","University of California San Francisco","2024-09-25","1","new results","cc_by_nc_nd","immunology","https://www.biorxiv.org/content/early/2024/09/25/2024.09.23.613776.source.xml","Macrophage-mediated phagocytosis is a vital innate immune process altered in cancer. We show here that tumor-associated macrophages (TAMs) redeploy intact cell surface proteins from cancer cells to their own cell surface. We initially observed the canonical epithelial cancer surface marker EPCAM on the surface of TAMs in primary human solid tumors but not paired peripheral blood macrophages. In a murine model of metastatic breast cancer, we also observed EPCAM on the surface of primary TAMs that have phagocytosed breast cancer cells. In a model of a myeloproliferative neoplasm, we again found engulfed cell-derived surface proteins on the surface of macrophages following phagocytosis. A co-culture system and proteomics assay that tags proteins based on their cell-of-origin revealed hundreds of cell surface proteins synthesized in cancer cells are present and fully intact on the surface of macrophages following phagocytosis. Furthermore, macrophages that redeploy a neutral amino acid transporter correspondingly show increased transport of an unnatural amino acid substrate. Widespread acquisition of proteins from engulfed cells may contribute to two critical TAM phenotypes: the inability to phagocytose and reprogrammed metabolism.","NA","biorxiv",1727302158081
"Inferring Effective Networks of Spiking Neurons Using a Continuous-Time Estimator of Transfer Entropy","10.1101/2024.09.22.614302","biorxiv",9.249999999999998,6.3999999999999995,9.249999999999998,9.249999999999998,9.249999999999998,"Shorten, D.; Priesemann, V.; Wibral, M.; Lizier, J. T.","David Shorten","The University of Adelaide","2024-09-23","1","new results","cc_by_nd","neuroscience","https://www.biorxiv.org/content/early/2024/09/23/2024.09.22.614302.source.xml","When analysing high-dimensional time-series datasets, the inference of effective networks has proven to be a valuable modelling technique. This technique produces networks where each target node is associated with a set of source nodes that are capable of providing explanatory power for its dynamics. Multivariate Transfer Entropy (TE) has proven to be a popular and effective tool for inferring these networks. Recently, a continuous-time estimator of TE for event-based data such as spike trains has been developed which, in more efficiently representing event data in terms of inter-event intervals, is significantly more capable of measuring multivariate interactions. The new estimator thus presents an opportunity to more effectively use TE for the inference of effective networks from spike trains, and we demonstrate in this paper for the first time its efficacy at this task. Using data generated from models of spiking neurons - for which the ground-truth connectivity is known - we demonstrate the accuracy of this approach in various dynamical regimes. We further show that it exhibits far superior inference performance to a pairwise TE-based approach as well as a recently-proposed convolutional neural network approach. Moreover, comparison with Generalised Linear Models (GLMs), which are commonly applied to spike-train data, showed clear benefits, particularly in cases of high synchrony. Finally, we demonstrate its utility in revealing the patterns by which effective connections develop from recordings of developing neural cell cultures.","NA","biorxiv",1727302158081
"Effects of cladribine on intrathecal and peripheral B and plasma cells","10.1101/2024.09.19.24313610","medrxiv",6.304,6.304,6.304,6.304,6.304,"Allen-Philbey, K.; Stephenson, S.; Doody, G. M.; MacDougall, A.; Aboulwafaali, M.; Ammoscato, F.; Andrews, M.; Gnanapavan, S.; Giovannoni, G.; Grigoriadou, S.; Hickey, A.; Holden, D.; Lock, H.; Papachatzaki, M.; Redha, I.; Baker, D.; Tooze, R.; Schmierer, K.","Klaus Schmierer","Queen Mary University of London","2024-09-23","1","PUBLISHAHEADOFPRINT","cc_by_nd","neurology","https://www.medrxiv.org/content/early/2024/09/23/2024.09.19.24313610.source.xml","Background. Cladribine is a deoxyadenosine analogue that can penetrate the blood-brain barrier. It is used to treat multiple sclerosis. However, the mechanistic understanding of the effect of this highly effective therapy on B cells and plasma cells in the central nervous system compartment is limited. Objectives. The CLADRIPLAS study examined the effect of cladribine on peripheral and intrathecal B and plasma cell biology in people with MS. Methods. Thirty-eight people with progressive MS ineligible for- or rejecting- treatment with licenced therapies were recruited and supplied a baseline lumbar puncture. Those exhibiting gadolinium-enhancing or new/enlarging T2 magnetic resonance imaging lesions and/or elevated neurofilament levels were offered subcutaneous cladribine (Litak). Seven people were eligible; one person died before treatment, and only five completed the first year of treatment. Twenty-two ineligible people were willing to provide a repeat lumbar puncture twelve months later. Results. The CLADRIPLAS study found no evidence of a difference in the odds of a positive cerebrospinal fluid oligoclonal band (cOCB) result between the cladribine-treated and untreated group. This is probably explained by microarray and in vitro studies, which demonstrated that plasmablasts and notably long-lived plasma cells are relatively resistant to the cytotoxic effect of cladribine compared to memory B cells at physiological concentrations. This was consistent with the loss of intracellular deoxycytidine kinase during antibody-secreting cell differentiation. Discussion. CLADRIPLAS indicates that cOCB are not rapidly eliminated in most people with MS. This may be explained by the relative lack of direct cytotoxic action of cladribine on long-lived plasma cells.","NA","medrxiv",1727302158081
"A helper NLR targets organellar membranes to trigger immunity","10.1101/2024.09.19.613839","biorxiv",46.250000000000014,6.300000000000001,46.250000000000014,46.250000000000014,46.250000000000014,"Ibrahim, T.; Yuen, E. L. H.; Wang, H.-Y.; King, F. J.; Toghani, A.; Kourelis, J.; Vuolo, C.; Adamkova, V.; Castel, B.; Jones, J. D.; Wu, C.-H.; Kamoun, S.; Bozkurt, T. O.","Tolga Osman Bozkurt","Imperial College London","2024-09-22","1","new results","cc_by_nc_nd","plant biology","https://www.biorxiv.org/content/early/2024/09/22/2024.09.19.613839.source.xml","In plants, NLR (nucleotide-binding domain and leucine-rich repeat) proteins execute innate immunity through the formation of resistosomes that accumulate at the plasma membrane. However, the extent to which NLR resistosomes target other cellular membranes is unknown. Here, we show that the helper NLR NRG1 engages with multiple organellar membranes to trigger innate immunity. Compared to other helper NLRs, NRG1 and closely related RPW8-like NLRs (CCR-NLRs) possess extended N-termini with distinctive sequence signatures, enabling their assembly into longer structures than canonical coiled coil NLR (CC-NLR) resistosomes. Activated NRG1 associates with single- and double-membrane organelles via its N-terminal RPW8-like domain. Our findings reveal that plant NLR resistosomes accumulate at a variety of cellular membrane sites to activate immunity.","NA","biorxiv",1727302158081
"T1234: A distortion-matched structural scan solution to misregistration of high resolution fMRI data","10.1101/2024.09.19.613939","biorxiv",5.3,5.3,5.3,5.3,5.3,"Kan, C.; Stirnberg, R.; Montequin, M.; Gulban, O. F.; Morgan, A. T.; Bandettini, P.; Huber, L.","Laurentius Huber","NIH, Bethesda, United States,","2024-09-20","1","new results","cc0","neuroscience","https://www.biorxiv.org/content/early/2024/09/20/2024.09.19.613939.source.xml","PurposeHigh-resolution fMRI at 7T is challenged by suboptimal alignment quality between functional data and structural scans. This study aims to develop a rapid acquisition method that provides distortion-matched, artifact-mitigated structural reference data.

MethodsWe introduce an efficient sequence protocol termed T1234, which offers adjustable distortions. This approach involves a T1-weighted 2-inversion 3D-EPI sequence with four spatial encoding directions optimized for high-resolution fMRI. A forward Bloch model was used for T1 quantification and protocol optimization. Twenty participants were scanned at 7T using both structural and functional protocols to evaluate the utility of T1234.

ResultsResults from two protocols are presented. A fast distortion-free protocol reliably produced whole-brain segmentations at 0.8mm isotropic resolution within 3:00-3:40 minutes. It demonstrates robustness across sessions, participants, and three different 7T SIEMENS scanners. For a protocol with geometric distortions that matched functional data, T1234 facilitates layer-specific fMRI signal analysis with enhanced laminar precision.

ConclusionThis structural mapping approach enables precise registration with fMRI data. T1234 has been successfully implemented, validated, and tested, and is now available to users at our center and at over 50 centers worldwide.","NA","biorxiv",1727302158081
"The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles","10.1101/2024.09.23.614520","biorxiv",4.9,4.9,4.9,4.9,4.9,"Straub, V. M.; Barti, B.; Tandar, S. T.; Stevens, A. F.; van der Wel, T.; Zhu, N.; Ruegger, J.; van der Horst, C.; Heitman, L. H.; Li, Y.; Stella, N.; van Hasselt, J. G. C.; Katona, I.; van der Stelt, M.","Mario van der Stelt","Leiden University","2024-09-24","1","new results","cc_no","neuroscience","https://www.biorxiv.org/content/early/2024/09/24/2024.09.23.614520.source.xml","While it is known that endocannabinoids (eCB) modulate multiple neuronal functions, the molecular mechanism governing their release and transport remains elusive. Here, we propose an 'on-demand release' model, wherein the formation of microvesicles, a specific group of extracellular vesicles (EVs) containing the eCB, 2-arachidonoylglycerol (2-AG), is the rate-limiting step. A co-culture model system that combines a reporter cell line expressing the fluorescent eCB sensor, GRABeCB2.0, and neuronal cells revealed that neurons release EVs containing 2-AG, but not anandamide, in a stimulus-dependent process regulated by PKC, DAGL, Arf6, and which was sensitive to inhibitors of eCB facilitated diffusion. A vesicle contained approximately 2000 2-AG molecules. Accordingly, hippocampal eCB-mediated synaptic plasticity was modulated by Arf6 and transport inhibitors. This 'on demand release' model, supported by mathematical analysis, offers a cohesive framework for understanding eCB signaling at the molecular level and suggests that microvesicles carrying signaling lipids regulate neuronal functions in parallel to canonical synaptic vesicles.","NA","biorxiv",1727302158081
"A lymphoid tissue chemokine checkpoint prevents loss of CD8+ T cell functionality","10.1101/2024.09.19.613830","biorxiv",4.800000000000001,4.800000000000001,4.800000000000001,4.800000000000001,4.800000000000001,"Altenburger, L. M.; Claudino Carvoeiro, D.; Dehio, P.; Zhou, J.; Laura, C.; Katoch, M.; Krueger, C.; Barreto de Albuquerque, J.; Pfenninger, P.; Martinez Magdaleno, J.; Abe, J.; Mehling, M.; Dengjel, J.; Iannacone, M.; Hashemi Gheinani, A.; Stein, J. V.","Jens V Stein","University of Fribourg","2024-09-22","1","new results","cc_by_nc_nd","immunology","https://www.biorxiv.org/content/early/2024/09/22/2024.09.19.613830.source.xml","The generation of effector CD8+ T cells (TEFF) requires activation of naive CD8+ T cells (TN) by dendritic cells (DCs) within lymphoid tissue. To date, it remains elusive how the duration of TN-DC interactions and integration of activation signals are controlled in vivo. Here, we report that lymphoid stroma-secreted ligands for CCR7 constrained interaction duration by gradually inducing CD8+ T cell release from DCs. At late time points of interactions, CCR7 ligands repositioned the F-actin-promoting factor DOCK2 away from the DC interface to enable CD8+ T cell detachment, proliferation onset and acquisition of cytotoxicity. Lack of CCR7 signaling, as during ex vivo activation or in chronically inflamed lymphoid tissue, caused sustained T cell-DC interactions, and generated dysfunctional TEFF with high expression of inhibitory receptors, impaired antimicrobial activity, and poor recall responses. In sum, our findings uncover that lymphoid stromal chemokines act as built-in ""disruptors"" of T cell-DC interactions for long-term preservation of TEFF functionality.","NA","biorxiv",1727302158081
"Complex genetic variation in nearly complete human genomes","10.1101/2024.09.24.614721","biorxiv",4.8,4.8,4.8,4.8,4.8,"Logsdon, G. A.; Ebert, P.; Audano, P. A.; Loftus, M.; Porubsky, D.; Ebler, J.; Yilmaz, F.; Hallast, P.; Prodanov, T.; Yoo, D.; Paisie, C. A.; Harvey, W. T.; Zhao, X.; Martino, G. V.; Henglin, M.; Munson, K. M.; Rabbani, K.; Chin, C.-S.; Gu, B.; Ashraf, H.; Austine-Orimoloye, O.; Balachandran, P.; Bonder, M. J.; Cheng, H.; Chong, Z.; Crabtree, J.; Gerstein, M.; Guethlein, L. A.; Hasenfeld, P.; Hickey, G.; Hoekzema, K.; Hunt, S. E.; Jensen, M.; Jiang, Y.; Koren, S.; Kwon, Y.; Li, C.; Li, H.; Li, J.; Norman, P. J.; Oshima, K. K.; Paten, B.; Phillippy, A. M.; Pollock, N. R.; Rausch, T.; Rautiainen","Tobias Marschall","Institute for Medical Biometry and Bioinformatics, Medical Faculty and University Hospital Dusseldorf, Heinrich Heine University, Dusseldorf, Germany","2024-09-25","1","new results","cc_by","genomics","https://www.biorxiv.org/content/early/2024/09/25/2024.09.24.614721.source.xml","Diverse sets of complete human genomes are required to construct a pangenome reference and to understand the extent of complex structural variation. Here, we sequence 65 diverse human genomes and build 130 haplotype-resolved assemblies (130 Mbp median continuity), closing 92% of all previous assembly gaps and reaching telomere-to-telomere (T2T) status for 39% of the chromosomes. We highlight complete sequence continuity of complex loci, including the major histocompatibility complex (MHC), SMN1/SMN2, NBPF8, and AMY1/AMY2, and fully resolve 1,852 complex structural variants (SVs). In addition, we completely assemble and validate 1,246 human centromeres. We find up to 30-fold variation in -satellite high-order repeat (HOR) array length and characterize the pattern of mobile element insertions into -satellite HOR arrays. While most centromeres predict a single site of kinetochore attachment, epigenetic analysis suggests the presence of two hypomethylated regions for 7% of centromeres. Combining our data with the draft pangenome reference significantly enhances genotyping accuracy from short-read data, enabling whole-genome inference to a median quality value (QV) of 45. Using this approach, 26,115 SVs per sample are detected, substantially increasing the number of SVs now amenable to downstream disease association studies.","NA","biorxiv",1727302158081
"Large-scale multi-omic analysis identifies noncoding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma","10.1101/2024.09.22.24314165","medrxiv",4.949999999999999,4.45,4.949999999999999,4.949999999999999,4.949999999999999,"Zhong, J.; O'Brien, A.; Patel, M.; Eiser, D.; Mobaraki, M.; Collins, I.; Wang, L.; Guo, K.; TruongVo, T.; Jermusyk, A.; O'Neill, M.; Dill, C. D.; Wells, A. D.; Leonard, M. E.; Pippin, J. A.; Grant, S. F. A.; Zhang, T.; Andresson, T.; Connelly, K. E.; Shi, J.; Arda, H. E.; Hoskins, J. W.; Amundadottir, L. T.","Jun Zhong","Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA","2024-09-24","2","PUBLISHAHEADOFPRINT","cc_by_nd","oncology","https://www.medrxiv.org/content/early/2024/09/24/2024.09.22.24314165.source.xml","Identification of somatic driver mutations in the noncoding genome remains challenging. To comprehensively characterize noncoding driver mutations for pancreatic ductal adenocarcinoma (PDAC), we first created genome-scale maps of accessible chromatin regions (ACRs) and histone modification marks (HMMs) in pancreatic cell lines and purified pancreatic acinar and duct cells. Integration with whole-genome mutation calls from 506 PDACs revealed 314 ACRs/HMMs significantly enriched with 3,614 noncoding somatic mutations (NCSMs). Functional assessment using massively parallel reporter assays (MPRA) identified 178 NCSMs impacting reporter activity (19.45% of those tested). Focused luciferase validation confirmed negative effects on gene regulatory activity for NCSMs near CDKN2A and ZFP36L2. For the latter, CRISPR interference (CRISPRi) further identified ZFP36L2 as a target gene (16.0 - 24.0% reduced expression, P = 0.023 - 0.0047) with disrupted KLF9 binding likely mediating the effect. Our integrative approach provides a catalog of potentially functional noncoding driver mutations and nominates ZFP36L2 as a PDAC driver gene.","NA","medrxiv",1727302158081
"Next-generation snow leopard population assessment tool: multiplex-PCR SNP panel for individual identification from feces","10.1101/2024.09.19.613565","biorxiv",3.7,3.7,3.7,3.7,3.7,"Solari, K. A.; Ahmad, S.; Armstrong, E. E.; Campana, M.; Ali, H.; Hameed, S.; Ullah, J.; Khan, B. U.; Nawaz, M. A.; Petrov, D. A.","Katherine A Solari","Stanford University","2024-09-24","1","new results","cc_no","genetics","https://www.biorxiv.org/content/early/2024/09/24/2024.09.19.613565.source.xml","Snow leopards, Panthera uncia, are under threat from numerous pressures and are the focus of a great deal of conservation efforts. However, their elusive nature makes it difficult to estimate population sizes. Current methods used to monitor local population sizes include visually identifying individuals from camera trap photos and genetically identifying individuals from fecal samples using microsatellite loci. Here, we present a new method for identifying snow leopard individuals from fecal samples using a multiplex PCR single nucleotide polymorphism (SNP) panel method. The SNP panel we present consists of 144 SNPs and utilizes next-generation sequencing technology, making it cheaper and easier than current microsatellite methods. We validate our SNP panel with paired tissue and fecal samples from zoo individuals, showing a minimum of 96.7% accuracy in allele calls per run. We then generate SNP data from 235 field-collected fecal samples from across Pakistan to show that the panel can reliably identify individuals from low-quality fecal samples of unknown age and is robust to contamination. We also show that our SNP panel has the capability to identify first-order relatives and provides insights into the geographic origin of samples. This SNP panel will empower the snow leopard research community in their efforts to assess local and global snow leopard population sizes. More broadly, we present a method for developing a SNP panel that utilizes open source software for SNP selection and primer design, Illumina sequencing technology, and a streamlined lab and bioinformatics protocol which can be used to create similar SNP panels for any species of interest for which adequate genomic reference data is available.","NA","biorxiv",1727302158081
"Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma Pathophysiology","10.1101/2024.09.19.613932","biorxiv",3.7,3.7,3.7,3.7,3.7,"Meena, D.; Shivakumar, D.; Rajkhowa, s.; Bhattacharya, N.; Solanki, P.; Chhipa, S.; Janu, V.; Garg, M.; Gosal, J. S.; Jha, S.","Sushmita Jha","Indian Institute of Technology Jodhpur","2024-09-20","1","new results","cc_no","cancer biology","https://www.biorxiv.org/content/early/2024/09/20/2024.09.19.613932.source.xml","Gliomas are primary brain tumors that develop from glial cells within the central nervous system and are among the deadliest human cancers. Glioblastoma (GBM) is the most malignant form of glioma. NLRX1 is an innate immune pattern recognition receptor that exhibits tumor-suppressive and tumor-promoting effects that may be cancer or cell-type, context-dependent, aided by differences in the microenvironment. Here, we report that NLRX1 is differentially expressed in microglia, astrocytes, GBM cell lines, and glioma patient tissues. siRNA-mediated silencing of Nlrx1 decreases the ability of the GBM cell line, LN-229, to proliferate and migrate. Nlrx1-/- GBM cells exhibit attenuated ability to generate 3D spheroids and enhanced capability to form tunneling nanotubes. Moreover, Nlrx1-/- GBM cells show decreased expression of autophagy markers, suggesting that NLRX1 plays a role in maintaining autophagy in GBM. In summary, our findings indicate that NLRX1 may modulate GBM pathophysiology by regulating GBM cell proliferation, migration, and metabolism. We believe our understanding of NLRX1 in GBM pathophysiology paves the potential development of GBM-targeting therapeutics that may delay disease progression and/or improve survival.","NA","biorxiv",1727302158081
"Genomic Surveillance for Enhanced Healthcare Outbreak Detection and Control","10.1101/2024.09.19.24313985","medrxiv",9.4,3.7,9.4,9.4,9.4,"Sundermann, A. J.; Kumar, P.; Griffith, M. P.; Waggle, K. D.; Rangachar Srinivasa, V.; Raabe, N.; Mills, E. G.; Coyle, H.; Ereifej, D.; Creager, H. M.; Ayres, A.; Van Tyne, D.; Pless, L. L.; Snyder, G. M.; Roberts, M.; Harrison, L. H.","Alexander J Sundermann","University of Pittsburgh","2024-09-22","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","infectious diseases","https://www.medrxiv.org/content/early/2024/09/22/2024.09.19.24313985.source.xml","BackgroundCurrent methods are insufficient alone for outbreak detection in hospitals. Real-time genomic surveillance using offers the potential to detect otherwise unidentified outbreaks. We initiated and evaluated the Enhanced Detection System for Healthcare-associated Transmission (EDS-HAT), a real-time genomic surveillance program for outbreak detection and mitigation.

MethodsThis study was conducted at UPMC Presbyterian Hospital from November 2021 to October 2023. Whole genome sequencing (WGS) was performed weekly on healthcare-associated clinical bacterial isolates to identify otherwise undetected outbreaks. Interventions were implemented in real-time based on identified transmission. A clinical and economic impact analysis was conducted to estimate infections averted and net cost savings.

ResultsThere were 3,921 bacterial isolates from patient healthcare-associated infections that underwent WGS, of which 476 (12.1%) clustered into 172 outbreaks (size range 2-16 patients). Of the outbreak isolates, 292 (61.3%) had an identified epidemiological link. Among the outbreaks with interventions, 95.6% showed no further transmission on the intervened transmission route. The impact analysis estimated that, over the two-year period, 62 infections were averted, with gross cost savings of $1,011,146, and net savings of $695,706, which translates to a 3.2-fold return on investment. Probabilistic sensitivity analysis showed EDS-HAT was cost-saving and more effective in 98% of simulations.

ConclusionReal-time genomic surveillance enabled the rapid detection and control of outbreaks in our hospital and resulted in economic benefits and improvement in patient safety. This study demonstrates the feasibility and effectiveness of integrating genomic surveillance into routine infection prevention practice, offering a paradigm shift in healthcare outbreak detection and control.","NA","medrxiv",1727302158081
"Stimulus-modulated approach to steady-state: A new paradigm for event-related fMRI.","10.1101/2024.09.20.613944","biorxiv",3.5500000000000003,3.5500000000000003,3.5500000000000003,3.5500000000000003,3.5500000000000003,"Mathew, R.; Eed, A.; Klassen, M.; Everling, S.; Menon, R. S.","Ravi S Menon","Western University","2024-09-24","1","new results","cc_by_nc_nd","physiology","https://www.biorxiv.org/content/early/2024/09/24/2024.09.20.613944.source.xml","Functional MRI (fMRI) studies discard the initial volumes acquired during the approach of the magnetization to its steady-state value. Here, we leverage the substantially higher temporal signal-to-noise ratio (tSNR) of these initial volumes to increase the sensitivity of event-related fMRI experiments. To do this, we introduce Acquisition Free Periods (AFPs) that allow for the full recovery of the magnetization, followed by equal-length task or baseline acquisition blocks (AB) of fMRI volumes. An appropriately placed stimulus in the AFP produces a Blood Oxygenation-Level-Dependent (BOLD) response that peaks during the initial high tSNR phase of the AB, yielding an ~50% reduction in the number of trials (relative to conventional fMRI) needed to achieve a given statistical threshold. The AFP allows flexibility for the presentation of auditory stimuli, uncontaminated recording of electrophysiological activity, physiological gating, as well as the ability to average aperiodic fMRI data using stimulus or response-locked signal acquisition.","NA","biorxiv",1727302158081
"Improved precision oncology question-answering using agentic LLM","10.1101/2024.09.20.24314076","medrxiv",3.7,3.45,3.7,3.7,3.7,"Das, R.; Maheswari, K.; Siddiqui, S.; Arora, N.; Paul, A.; Nanshi, J.; Udbalkar, V.; Sarvade, A.; Chaturvedi, H.; Shvartsman, T.; Masih, S.; Thippeswamy, R.; Patil, S.; Nirni, S. S.; Garsson, B.; Bandyopadhyay, S.; Maulik, U.; Farooq, M.; Sengupta, D.","Debarka Sengupta","GeneSilico, Inc., 3267 Bee Caves Rd, STE 107-332 Austin, TX 78764","2024-09-24","1","PUBLISHAHEADOFPRINT","cc_no","oncology","https://www.medrxiv.org/content/early/2024/09/24/2024.09.20.24314076.source.xml","Despite the widespread application of Large Language Models (LLMs) in biomedical research, their clinical adoption faces significant challenges. These challenges stem from concerns about the quality, accuracy, and comprehensiveness of LLM-generated answers. Most existing work has focused on fine-tuning LLMs based on foundation models, which have not yet fully addressed accuracy and reliability issues. In this work, we propose an agent-based approach that aims to make LLM-based systems clinically deployable for precision oncology, while mitigating common pitfalls such as hallucinations, incoherence, and ""lost-in-the-middle"" problems. To achieve this, we implemented an agentic architecture, fundamentally shifting an LLM's role from a simple response synthesizer to planner. This agent orchestrates a suite of specialized tools that asynchronously retrieve information from various sources. These tools include curated document vector stores encompassing treatment guidelines, genomic data, clinical trial information, drug data, and breast cancer literature. The LLM then leverages its planning capabilities to synthesize information retrieved by these tools, generating comprehensive and accurate responses. We demonstrate GeneSilico Copilot's effectiveness in the domain of breast cancer, achieving state-of-the-art accuracy. Furthermore, the system showcases success in generating personalized oncotherapy recommendations for real-world cases.","NA","medrxiv",1727302158081
"Prediction and design of transcriptional repressor domains with large-scale mutational scans and deep learning","10.1101/2024.09.21.614253","biorxiv",3.35,3.35,3.35,3.35,3.35,"Valbuena, R.; Nigam, A.; Tycko, J.; Suzuki, P.; Spees, K.; Aradhana, A.; Arana, S.; Du, P.; Patel, R. A.; Bintu, L.; Kundaje, A.; Bassik, M. C.","Michael C Bassik","Stanford","2024-09-24","1","new results","cc_no","genomics","https://www.biorxiv.org/content/early/2024/09/24/2024.09.21.614253.source.xml","Regulatory proteins have evolved diverse repressor domains (RDs) to enable precise context-specific repression of transcription. However, our understanding of how sequence variation impacts the functional activity of RDs is limited. To address this gap, we generated a high-throughput mutational scanning dataset measuring the repressor activity of 115,000 variant sequences spanning more than 50 RDs in human cells. We identified thousands of clinical variants with loss or gain of repressor function, including TWIST1 HLH variants associated with Saethre-Chotzen syndrome and MECP2 domain variants associated with Rett syndrome. We also leveraged these data to annotate short linear interacting motifs (SLiMs) that are critical for repression in disordered RDs. Then, we designed a deep learning model called TENet (Transcriptional Effector Network) that integrates sequence, structure and biochemical representations of sequence variants to accurately predict repressor activity. We systematically tested generalization within and across domains with varying homology using the mutational scanning dataset. Finally, we employed TENet within a directed evolution sequence editing framework to tune the activity of both structured and disordered RDs and experimentally test thousands of designs. Our work highlights critical considerations for future dataset design and model training strategies to improve functional variant prioritization and precision design of synthetic regulatory proteins.","NA","biorxiv",1727302158081
"Cytotoxicity of Activator Expression in CRISPR-based Transcriptional Activation Systems","10.1101/2024.09.23.614524","biorxiv",3.35,3.35,3.35,3.35,3.35,"Maddineni, A.; Liang, Z.; Jambardi, S.; Roy, S.; Tycko, J.; Patil, A.; Manzano, M.; Gottwein, E.","Eva Gottwein","Northwestern University, Feinberg School of Medicine","2024-09-23","1","new results","cc_by_nc_nd","molecular biology","https://www.biorxiv.org/content/early/2024/09/23/2024.09.23.614524.source.xml","CRISPR-based transcriptional activation (CRISPRa) has extensive research and clinical potential. Here, we show that commonly used CRISPRa systems can exhibit pronounced cytotoxicity. We demonstrate the toxicity of published and new CRISPRa vectors expressing the activation domains (ADs) of the transcription factors p65 and HSF1, components of the synergistic activation mediator (SAM) CRISPRa system. Based on our findings for the SAM system, we extended our studies to additional ADs and the p300 acetyltransferase core domain. We show that the expression of potent transcriptional activators in lentiviral producer cells leads to low lentiviral titers, while their expression in the transduced target cells leads to cell death. Using inducible lentiviral vectors, we could not identify an activator expression window for effective SAM-based CRISPRa without measurable toxicity. The toxicity of current SAM-based CRISPRa systems hinders their wide adoption in biomedical research and introduces selection bottlenecks that may confound genetic screens. Our results suggest that the further development of CRISPRa technology should consider both the efficiency of gene activation and activator toxicity.","NA","biorxiv",1727302158081
"A toolbox for ablating excitatory and inhibitory synapses","10.1101/2024.09.23.614589","biorxiv",3.25,3.25,3.25,3.25,3.25,"Bareghamyan, A.; Deng, C.; Daoudi, S.; Nawy, S.; Lu, X.; Zhang, W.; Campbell, R. E.; Kramer, R.; Chenoweth, D. M.; Arnold, D. B.","Don B Arnold","University of Southern California","2024-09-24","1","new results","cc_by_nc_nd","neuroscience","https://www.biorxiv.org/content/early/2024/09/24/2024.09.23.614589.source.xml","Recombinant optogenetic and chemogenetic proteins that manipulate neuronal activity are potent tools for activating and inhibiting neuronal circuit function. However, there are few analogous tools for manipulating the structure of neural circuits. Here, we introduce three rationally designed genetically encoded tools that use E3 ligase-dependent mechanisms to trigger the degradation of synaptic scaffolding proteins, leading to functional ablation of synapses. First, we developed a constitutive excitatory synapse ablator, PFE3, analogous to the inhibitory synapse ablator GFE3. PFE3 targets the RING domain of the E3 ligase Mdm2 and the proteasome-interacting region of Protocadherin 10 to the scaffolding protein PSD-95, leading to efficient ablation of excitatory synapses. In addition, we developed a light-inducible version of GFE3, paGFE3, using a novel photoactivatable complex based on the photocleavable protein PhoCl2c. paGFE3 degrades Gephyrin and ablates inhibitory synapses in response to 400 nm light. Finally, we developed a chemically inducible version of GFE3, chGFE3, which degrades inhibitory synapses when combined with the bio-orthogonal dimerizer, HaloTag ligand-trimethoprim. Each tool is specific, reversible, and capable of breaking neural circuits at precise locations.","NA","biorxiv",1727302158081
"Single-stranded HDR templates with truncated Cas12a binding sequences improve knock-in efficiencies in primary human T cells","10.1101/2024.09.11.608426","biorxiv",3.25,3.25,3.25,3.25,3.25,"Nitulescu, A.-M.; Du, W.; Glaser, V.; Kath, J.; Greensmith, R.; Mikkelsen, N. S.; Stein, M.; Bak, R.; Kaminski, M.; Wagner, D. L.","Dimitrios Laurin Wagner","Charite - Universitaetsmedizin Berlin","2024-09-11","1","new results","cc_no","immunology","https://www.biorxiv.org/content/early/2024/09/11/2024.09.11.608426.source.xml","Non-viral gene editing via CRISPR-Cas12a offers an alternative to Cas9-based methods, providing better targeting of AT-rich regions, simplified guide RNA manufacturing, and high specificity. However, the efficacy of editing outcomes is subject to various factors, with template format playing a crucial role. Currently, the predominant non-viral template format for inducing homology-directed repair (HDR) after nuclease-induced DNA breaks is double-stranded DNA (dsDNA), which is toxic when transfected at high doses. Previous studies have demonstrated that using single-stranded DNA (ssDNA) with flanking double-stranded Cas-target-sequences (CTS) as a repair template for Cas9-mediated gene editing can mitigate this toxicity and increase knock-in efficiency. Here, we investigate CTS design for AsCas12a Ultra by exploring PAM orientation and binding requirements of the Cas12a-crRNA complex. Additionally, we rule out in vitro ssDNase activity of AsCas12a Ultra under cell-physiological Mg2+ conditions. Finally, we showcase the advantage of using ssDNA with double-stranded CTS end modifications (ssCTS) at high doses for delivering clinically relevant transgenes of varying sizes into three T-cell receptor-CD3 complex genes (TRAC, CD3{zeta}, CD3{varepsilon}), achieving up to 90% knock-in rates for a 0.8kb insert at the CD3{varepsilon} locus. Overall, AsCas12a Ultra and ssCTS donors represent a platform for highly efficient knock-in in primary human T cells with minimal toxicity.","NA","biorxiv",1727302158081
"Heterozygous loss-of-function variants in SPTAN1 cause a novel early childhood onset distal myopathy with chronic neurogenic features","10.1101/2024.09.23.24313872","medrxiv",3.2,3.2,3.2,3.2,3.2,"De Winter, J.; Van de Vondel, L.; Ermanoska, B.; Monticelli, A.; Isapof, A.; Cohen, E.; Stojkovic, T.; Hackman, P.; Johari, M.; Palmio, J.; Waldrop, M. A.; Meyer, A. P.; Nicolau, S.; Flanigan, K. M.; Topf, A.; Diaz-Manera, J.; Straub, V.; Longman, C.; McWilliam, C. A.; Orbach, R.; Verma, S.; Laine, R.; Donkervoort, S.; Bonnemann, C. G.; Rebelo, A.; Zuchner, S.; Grider, T.; Shy, M. E.; Maystadt, I.; Demurger, F.; Cairns, A.; Beecroft, S.; Folland, C.; De Ridder, W.; Ravenscroft, G.; Bonne, G.; Udd, B.; Baets, J.","Jonathan Baets","Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Laboratory of Neuromuscular Pathology, Institute ","2024-09-24","1","PUBLISHAHEADOFPRINT","cc_no","neurology","https://www.medrxiv.org/content/early/2024/09/24/2024.09.23.24313872.source.xml","Background: Neurogenetic disorders caused by pathogenic variants in four genes encoding non-erythrocytic spectrins (SPTAN1, SPTBN1, SPTBN2, SPTBN4) range from peripheral and central nervous system involvement to complex syndromic presentations. Heterozygous pathogenic variants in SPTAN1 are exemplary for this diversity with phenotypes spanning almost the entire spectrum. Methods: Through international collaboration we identified 14 families with genetically unsolved distal weakness and unreported heterozygous SPTAN1 loss-of-function variants including frameshift, nonsense and splice-acceptor variants. Clinical data, electrophysiology, muscle CT or MRI and muscle biopsy findings were collected and standardized. SPTAN1 protein, mRNA expression analysis and cDNA sequencing was performed on muscle tissue from two patients. Results: All 20 patients presented with early childhood onset distal weakness. The severity varied both within families and between different families. Foot abnormalities ranged from hammer toes and pes cavus to distal arthrogryposis. Electrophysiology showed mixed myogenic and neurogenic features. Muscle MRI or CT in 10 patients showed fatty infiltration of the distal lower limb anterior compartment and/or selective involvement of the extensor hallucis longus muscle. Muscle biopsy revealed myopathic changes with mild dystrophic and chronic neurogenic changes in 7 patients. Finally, we provide proof for nonsense mediated decay in tissues derived from two patients. Conclusions: We provide evidence for the association of SPTAN1 loss-of-function variants with childhood onset distal myopathy in 14 families. This finding extends the phenotypic spectrum of SPTAN1 loss-of-function variants ranging from intellectual disability to distal weakness with a predominant myogenic cause.","NA","medrxiv",1727302158081
"Toxicity of extracellular cGAMP and its analogs to T cells is due to SLC7A1-mediated import","10.1101/2024.09.21.614248","biorxiv",3.1,3.1,3.1,3.1,3.1,"Sudaryo, V.; R. Carvalho, D.; Lee, J. M.; Carozza, J. A.; Cao, X.; Cordova, A. F.; Li, L.","Lingyin Li","Stanford University/ Arc Institute","2024-09-24","1","new results","cc_no","immunology","https://www.biorxiv.org/content/early/2024/09/24/2024.09.21.614248.source.xml","STING agonists are promising innate immune therapies and can synergize with adaptive immune checkpoint blockade therapies for cancer treatment, but their effectiveness is limited by the toxicity to activated T cells. An important class of STING agonists are analogs of the endogenous STING agonist, cGAMP, and while transporters for these small molecules are known in some cell types, how they enter and kill T cells remains unknown. Here, we identify the cationic amino acid transporter SLC7A1 as the dominant transporter of cGAMP and its analogs in activated primary mouse and human T cells. T cells upregulate this transporter upon activation and rapid proliferation to meet their high metabolic demand, but this comes at the cost of enabling increased transport and toxicity of cGAMP. To circumvent the essentiality of SLC7A1 to proliferating T cells, we found that the residues responsible for cGAMP transport are separate from the arginine binding pocket allowing us to perturb cGAMP transport and STING-activation mediated killing without impacting arginine transport. These results suggest that SLC7A1 is a potential target for alleviating T cell toxicity associated with cGAMP and its analogs.","NA","biorxiv",1727302158081
"Characterization and implication of the Orai3 channel and ABC type transporters in the phenomenon of chemoresistance to cisplatin and pemetrexed in lung cancer.","10.1101/2024.09.22.613742","biorxiv",3,3,3,3,3,"Daoudi, R.","Redoane Daoudi","University of Caen Normandy 14000 FRANCE","2024-09-24","1","new results","cc_no","cancer biology","https://www.biorxiv.org/content/early/2024/09/24/2024.09.22.613742.source.xml","Orai3 channels have been associated with cell proliferation, survival and metastasis in several cancers. Previous studies have shown that Orai3 seems to be involved in the development of acquired chemo-resistance of cisplatin in non-small cell lung cancer via ABC transporters that transport certain chemotherapeutic agents, such as cisplatin, out of the cells. Based on these studies, we hypothesize that Orai3 may be involved in the development of acquired chemo-resistance of pemetrexed. By using MTT assay, we show that pemetrexed is efficient and signiftcantly decreases cell viability in a dose dependent manner. Furthermore, we demonstrate using siRNA-mediated Orai3 knockdown that Orai3 silencing has no effect on the chemoresistance against pemetrexed. Then, calcium imaging reveals that pemetrexed does not affect the activity of calcium channels like Orai3. As transcription factors are central to the regulation of gene expression, we wonder if pemetrexed could impact on Orai3 expression. To address the issue, Mn2+ -quench assays are performed in siOrai3 transfected A549 cells incubated with 1uM pemetrexed for 72h. Finally, RT-PCR is used in order to determine the mRNA expression proftle for Orai3 and ABC transporters in A549 cells. We demonstrate that pemetrexed increases Orai3 expression. Taken together, these results suggest that Orai3 is not involved in the development of acquired chemo-resistance of pemetrexed in non small cell lung cancer. Pemetrexed upregulates Orai3 expression but does not affect the activity of Orai3 channels. As Orai3 channels are known to be involved in the development of acquired chemoresistance of cisplatin in non-small cell lung cancer, pemetrexed could reduce the therapeutic efficacy of cisplatin if Orai3 protein levels are linked to Orai3 mRNA levels. Moreover, cisplatin has been shown to increase both expression and function of Orai3, resulting in increased chemoresistance. Therefore, our results show that Orai3 could constitute a robust therapeutic target in non-small cell lung cancer.","NA","biorxiv",1727302158081
"Shigella flexneri evades LPS ubiquitylation through IpaH1.4-mediated degradation of RNF213","10.1101/2024.09.24.614686","biorxiv",2.95,2.95,2.95,2.95,2.95,"Naydenova, K.; Boyle, K. B.; Pathe, C.; Pothukuchi, P.; Crespillo-Casado, A.; Scharte, F.; Hammoudi, P.-M.; Otten, E. G.; Randow, F.","Felix Randow","MRC Laboratory of Molecular Biology","2024-09-24","1","new results","cc_no","molecular biology","https://www.biorxiv.org/content/early/2024/09/24/2024.09.24.614686.source.xml","The evolutionary arms race between pathogens and hosts has resulted in pathogens acquiring diverse adaptive countermeasures that antagonize host immunity. Ubiquitylation of lipopolysaccharide (LPS) on cytosol-invading bacteria by the E3 ligase RNF213 creates 'eat-me' signals for antibacterial autophagy but whether and how cytosol-adapted bacteria avoid LPS ubiquitylation remains poorly understood. Here we show that Shigella flexneri, a professional cytosol-dwelling enterobacterium, actively antagonizes LPS ubiquitylation through IpaH1.4, a secreted effector protein with ubiquitin E3 ligase activity. IpaH1.4 binds to the LPS E3 ubiquitin ligase RNF213, ubiquitylates it, and targets it for degradation by the proteasome, thus preventing LPS ubiquitylation. To understand how IpaH1.4 recognizes RNF213, we determined the structure of their complex using cryogenic electron microscopy. The specificity of the interaction is achieved via the leucine rich repeat of IpaH1.4, which binds the RING domain of RNF213 by hijacking the conserved RING interface required for binding of ubiquitin-charged E2 enzymes. Interestingly, IpaH1.4 also targets the E3 ligase LUBAC - required for the synthesis of M1-linked ubiquitin chains on cytosol-invading bacteria downstream of RNF213 - as well as multiple other E3 ligases involved in inflammation and immunity - through binding to the E2-interacting face of their RING domains. We conclude that IpaH1.4 has evolved to antagonize multiple anti-bacterial and pro-inflammatory host E3 ligases.","NA","biorxiv",1727302158081
"Hippocampal representations of alternative possibilities are flexibly generated to meet cognitive demands","10.1101/2024.09.23.613567","biorxiv",2.85,2.85,2.85,2.85,2.85,"Comrie, A. E.; Monroe, E. J.; Kahn, A. E.; Denovellis, E. L.; Joshi, A.; Guidera, J. A.; Krausz, T. A.; Berke, J. D.; Daw, N. D.; Frank, L. M.","Loren M. Frank","University of California, San Francisco","2024-09-23","1","new results","cc_by_nc_nd","neuroscience","https://www.biorxiv.org/content/early/2024/09/23/2024.09.23.613567.source.xml","The cognitive ability to go beyond the present to consider alternative possibilities, including potential futures and counterfactual pasts, can support adaptive decision making. Complex and changing real-world environments, however, have many possible alternatives. Whether and how the brain can select among them to represent alternatives that meet current cognitive needs remains unknown. We therefore examined neural representations of alternative spatial locations in the rat hippocampus during navigation in a complex patch foraging environment with changing reward probabilities. We found representations of multiple alternatives along paths ahead and behind the animal, including in distant alternative patches. Critically, these representations were modulated in distinct patterns across successive trials: alternative paths were represented proportionate to their evolving relative value and predicted subsequent decisions, whereas distant alternatives were prevalent during value updating. These results demonstrate that the brain modulates the generation of alternative possibilities in patterns that meet changing cognitive needs for adaptive behavior.","NA","biorxiv",1727302158081
"Generation of an inducible destabilized-domain Cre mouse line to target disease associated microglia","10.1101/2024.09.18.613773","biorxiv",2.85,2.85,2.85,2.85,2.85,"Henningfield, C. M.; Kwang, N.; Tsourmas, K. I.; Neumann, J.; Kawauchi, S.; Swarup, V.; MacGregor, G. R.; Green, K. N.","Kim N Green","University of California, Irvine","2024-09-19","1","new results","cc_no","neuroscience","https://www.biorxiv.org/content/early/2024/09/19/2024.09.18.613773.source.xml","The function of microglia during progression of Alzheimers disease (AD) can be investigated using mouse models that enable genetic manipulation of microglial subpopulations in a temporal manner. We developed a mouse strain that expresses destabilized-domain Cre recombinase (DD-Cre) from the Cst7 locus (Cst7DD-Cre) and tested this in 5xFAD amyloidogenic, Ai14 tdTomato cre-reporter line mice. Dietary administration of trimethoprim to induce DD-Cre activity produces long-term labeling in disease associated microglia (DAM) without evidence of leakiness, with tdTomato-expression restricted to cells surrounding plaques. Using this model, we found that DAMs are a subset of plaque-associated microglia (PAMs) and their transition to DAM increases with age and disease stage. Spatial transcriptomic analysis revealed that tdTomato+ cells show higher expression of disease and inflammatory genes compared to other microglial populations, including non-labeled PAMs. This model should allow inducible cre-loxP targeting of DAMs, without leakiness.

HighlightsO_LIWe developed a new mouse strain which specifically enables recombination of loxP sites in disease associated microglia (DAMs) and can be used to manipulate DAM-gene expression.
C_LIO_LIDAMs represent a subset of plaque associated microglia (PAMs), and DAM expression increases with disease progression.
C_LIO_LISpatial transcriptomic analyses reveal that DAMs have higher expression of disease and inflammatory genes compared to other PAMs.
C_LI","NA","biorxiv",1727302158081
"Year-long assessment of the immune response elicited by MVA-BN vaccine","10.1101/2024.09.20.24313813","medrxiv",2.85,2.85,2.85,2.85,2.85,"Matusali, G.; Cimini, E.; Mazzotta, V.; Colavita, F.; Maggi, F.; Antinori, A.","Valentina Mazzotta","INMI Lazzaro Spallanzani IRCCS, Rome","2024-09-23","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","infectious diseases","https://www.medrxiv.org/content/early/2024/09/23/2024.09.20.24313813.source.xml","Background Modified-Vaccinia-Ankara Bavarian Nordic (MVA-BN) vaccine has been recommended to tackle the mpox epidemic 2022-2023 and its resurgence in 2024. Although its effectiveness has been estimated to range between 36-86%, the persistence of protection is still unknown. Aims of this study is to assess the immune response one year after vaccination with MVA-BN. Methods Observational prospective study at the National Institute for Infectious Diseases in Rome. All people at high risk for mpox infection who received MVA-BN as pre-exposure prophylaxis were enrolled. People previously primed with smallpox vaccination received a single-dose course of MVA-BN, while non-primed received a two-dose course. Blood samples were collected at the time of each dose and one, six and 12 months after vaccination. MPXV-specific IgG and neutralizing antibody (nAb) titers were assessed by immunofluorescence and plaque neutralization tests, respectively. Interferon-gamma producing T-cell specific response to the MVA-BN vaccine was analyzed by ELISpot assay. Antibody titers at pre- and post-vaccination were compared using the Friedman tests. Mann Whitney test was used to compare antibody titers in PLWH vs PLWoH. Wilcoxon and Mann-Whitney non-parametric tests were used to compare T-cells specific response to the MVA-BN vaccine for intra and inter-group differences, respectively. Results Fifty high-risk people were included. All were men, with 94% self-reporting having sex with men. The median age was 50 years (IQR 45-57), and 21 (42%) were people living with HIV (PLWH), all on antiretroviral therapy, and 71% with a CD4 cell count higher than 500 mmc. 25 (50%) have been primed with previous smallpox vaccination. In non-primed people, anti-MPXV IgG titers significantly increased from T1 to T3 and, despite a slight reduction, were still higher than T1 up to T4 and then gradually decreased until T5, when 64% of sera were still reactive. MPXV-nAb titers peaked at T3 and then dropped, with 56% and 32% of sera reactive at T4 and T5, respectively. IFN-g; production by MVA-BN-specific T-cells progressively rose across time, peaked at T3, and remained significantly higher than the baseline after 6 and 12 months from vaccination. A single-dose course of MVA-BN vaccination in smallpox-primed participants elicited an early increase in IgG and nAb titers, which remained significantly higher than baseline after 6 and 12 months. MPXV-nAbs were detected in 80% and 72% of vaccinees at T4 and T5, respectively. A similar improvement and maintenance were observed for the MVA-BN-specific T-cell response. No evidence for a difference in both humoral and cellular responses was found between PLWH and PLWoH in our cohort. Conclusions One year after vaccination, our data showed the persistent detectability of low levels of nAb against MPXV in one-third of non-primed individuals. At the same time, humoral response was still detectable in most previously vaccinated participants. Concurrently, the MVA-BN-specific T-cell response was robust and persistent.","NA","medrxiv",1727302158081
"Pediatric Long COVID Subphenotypes: An EHR-based study from the RECOVER program","10.1101/2024.09.17.24313742","medrxiv",7.1,2.75,4.75,7.1,7.1,"Lorman, V.; Bailey, L. C.; Song, X.; Rao, S.; Hornig, M.; Utidjian, L.; Razzaghi, H.; Mejias, A.; Leikauf, J. E.; Brill, S. B.; Allen, A.; Bunnell, H. T.; Reedy, C.; Mosa, A. S. M.; Horne, B. D.; Geary, C. R.; Chuang, C. H.; Williams, D. A.; Christakis, D. A.; Chrischilles, E. A.; Mendonca, E. A.; Cowell, L. G.; MocCorkell, L.; Liu, M.; Cummins, M. R.; Jhaveri, R.; Blecker, S.; Forrest, C. B.","Vitaly Lorman","Applied Clinical Research Center, Children\'s Hospital of Philadelphia","2024-09-18","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","pediatrics","https://www.medrxiv.org/content/early/2024/09/18/2024.09.17.24313742.source.xml","Pediatric Long COVID has been associated with a wide variety of symptoms, conditions, and organ systems, but distinct clinical presentations, or subphenotypes, are still being elucidated. In this exploratory analysis, we identified a cohort of pediatric (age <21) patients with evidence of Long COVID and no pre-existing complex chronic conditions using electronic health record data from 38 institutions and used an unsupervised machine learning-based approach to identify subphenotypes. Our method, an extension of the Phe2Vec algorithm, uses tens of thousands of clinical concepts from multiple domains to represent patients clinical histories to then identify groups of patients with similar presentations. The results indicate that cardiorespiratory presentations are most common (present in 54% of patients) followed by subphenotypes marked (in decreasing order of frequency) by musculoskeletal pain, neuropsychiatric conditions, gastrointestinal symptoms, headache, and fatigue.","NA","medrxiv",1727302158081
"HiFi long-read genomes for difficult-to-detect clinically relevant variants","10.1101/2024.09.17.24313798","medrxiv",20.200000000000003,2.7,8.1,20.200000000000003,20.200000000000003,"Hoeps, W.; Weiss, M. M.; Derks, R.; Corominas Galbany, J.; den Ouden, A.; van den Heuvel, S.; Timmermans, R.; Smits, J.; Mokveld, T.; Dolzhenko, E.; Chen, X.; van den Wijngaard, A.; Eberle, M. A.; Yntema, H. G.; Hoischen, A.; Gilissen, C.; Vissers, L. E. L. M.","Christian Gilissen","Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands","2024-09-19","1","PUBLISHAHEADOFPRINT","cc_by","genetic and genomic medicine","https://www.medrxiv.org/content/early/2024/09/19/2024.09.17.24313798.source.xml","Clinical short-read exome and genome sequencing approaches have positively impacted diagnostic testing for rare diseases. Yet, technical limitations associated with short reads challenge their use for detection of disease-associated variation in complex regions of the genome. Long-read sequencing (LRS) technologies may overcome these challenges, potentially qualifying as a first-tier test for all rare diseases. To test this hypothesis, we performed LRS (30x HiFi genomes) for 100 samples with 145 known clinically relevant germline variants that are challenging to detect using short-read sequencing and necessitate a broad range of complementary test modalities in diagnostic laboratories.

We show that relevant variant callers readily re-identify the majority of variants (120/145, 83%), including [~]90% of structural variants, SNVs/InDels in homologous sequences and expansions of short tandem repeats. Another 10% (n=14) was visually apparent in the data but not automatically detected. Our analyses also identified systematic challenges for the remaining 7% (n=11) of variants such as the detection of AG-rich repeat expansions. Titration analysis showed that 89% of all automatically called variants could also be identified using 15-fold coverage.

Thus, long-read genomes identified 93% of pathogenic variants that are most challenging to detect using short-read technologies. Even with reduced coverage, the vast majority of variants remained detectable, possibly enhancing cost-effective diagnostic implementation. Most importantly, we show the potential to use a single technology to accurately identify all types of clinically relevant variants.","NA","medrxiv",1727302158081
"SARS-CoV-2 Surveillance in US Wastewater: Leading Indicators and Data Variability Analysis in the 2023-2024 Season","10.1101/2024.08.28.24312739","medrxiv",13.2,2.7,2.7,2.7,13.2,"Schenk, H.; Rauch, W.; Zulli, A.; Boehm, A.","Alexandria Boehm","Stanford University","2024-08-28","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","epidemiology","https://www.medrxiv.org/content/early/2024/08/28/2024.08.28.24312739.source.xml","Wastewater-Based Epidemiology (WBE) has become a powerful tool for assessing disease occurrence in communities. This study investigates the coronavirus disease 2019 (COVID-19) epidemic in the United States during the 2023-2024 season using wastewater data from 189 wastewater treatment plants in 40 states and the District of Columbia. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and pepper-mild mottle virus normalized SARS-CoV-2 concentration data were compared with COVID-19 hospitalization admission data at both national and state levels. We further investigate temporal features in wastewater viral abundance, with peak timing and cross-correlation lag analyses indicating that wastewater SARS-CoV-2 concentrations precede hospitalization admissions by 2 to 12 days. Lastly, we demonstrate that wastewater treatment plant size, assessed by number of population served, has a significant effect on the variability of measured SARS-CoV-2 concentrations. This study highlights the effectiveness of WBE as a non-invasive, timely and resource-efficient disease monitoring strategy, especially in the context of declining COVID-19 clinical reporting.","NA","medrxiv",1727302158081
"TWINKLE: An open-source two-photon microscope for teaching and research","10.1101/2024.09.23.612766","biorxiv",2.5,2.5,2.5,2.5,2.5,"Schottdorf, M.; Rich, P. D.; Diamanti, E. M.; Lin, A.; Tafazoli, S.; Nieh, E. H.; Thiberge, S. Y.","Stephan Y. Thiberge","Princeton University","2024-09-23","1","new results","cc_by","neuroscience","https://www.biorxiv.org/content/early/2024/09/23/2024.09.23.612766.source.xml","Many laboratories use two-photon microscopy through commercial suppliers, or homemade designs of considerable complexity. The integrated nature of these systems complicates customization, troubleshooting as well as grasping the principles of two-photon microscopy. Here, we present ""Twinkle"": a microscope for Two-photon Imaging in Neuroscience, and Kit for Learning and Education. It is a fully open, high-performance and cost-effective research and teaching microscope without any custom parts beyond what can be fabricated in a university machine shop. The instrument features a large field of view, using a modern objective with a long working distance and large back aperture to maximize the fluorescence signal. We document our experiences using this system as a teaching tool in several two week long workshops, exemplify scientific use cases, and conclude with a broader note on the place of our work in the growing space of open-source scientific instrumentation.","NA","biorxiv",1727302158081
"DrugTar Improves Druggability Prediction by Integrating Large Language Models and Gene Ontologies","10.1101/2024.09.21.614218","biorxiv",2.5,2.5,2.5,2.5,2.5,"Borhani, N.; Izadi, I.; Motahharynia, A.; Sheikholeslami, M.; Gheisari, Y.","Yousof Gheisari","Isfahan University of Medical Sciences","2024-09-24","1","new results","cc_no","systems biology","https://www.biorxiv.org/content/early/2024/09/24/2024.09.21.614218.source.xml","Target discovery is crucial in drug development, especially for complex chronic diseases. Recent advances in high-throughput technologies and the explosion of biomedical data have highlighted the potential of computational druggability prediction methods. However, most current methods rely on sequence-based features with machine learning, which often face challenges related to hand-crafted features, reproducibility, and accessibility. Moreover, the potential of raw sequence and protein structure has not been fully investigated. Here, we leveraged both protein sequence and structure using deep learning techniques, revealing that protein sequence, especially pre-trained embeddings, is more informative than protein structure. Next, we developed DrugTar, a high-performance deep learning algorithm integrating sequence embeddings from the ESM-2 pre-trained protein language model with protein ontologies to predict druggability. DrugTar achieved areas under the curve and precision-recall curve values above 0.90, outperforming state-of-the-art methods. In conclusion, DrugTar streamlines target discovery as a bottleneck in developing novel therapeutics.","NA","biorxiv",1727302158081
"Sample size considerations for species co-occurrence models.","10.1101/2024.09.20.614180","biorxiv",3.95,2.45,3.95,3.95,3.95,"Cowans, A.; Bonet Bigata, A.; Sutherland, C.","Amber Cowans","University of St Andrews","2024-09-23","1","new results","cc_by_nc_nd","ecology","https://www.biorxiv.org/content/early/2024/09/23/2024.09.20.614180.source.xml","The multi-species occupancy model of Rota et al. (2016) is widely applied for inferences about interactions in the occurrence of different species, but convergence and estimation issues under realistic sample sizes are common. We conducted a simulation study to evaluate the ability to recover co-occurrence estimates using standard and penalised likelihood under varying sample size and interaction scenarios while increasing model complexity in two dimensions: the number of interacting species and the number of covariates. We demonstrate that the ability to quantify interactions in species occupancy using these models is highly sensitive to sample size and interaction strength. Even in the simplest scenario, there is high bias and low coverage in natural parameters (used for inference) for sample sizes below 400 sites. Strong co-occurrence is detected consistently above 400 sites, but weak co-occurrence is never consistently detected even with 3000 sites. We demonstrate that mean predictive ability is less affected by sample size and complexity, with low bias in derived probabilities at 100 sites. We caution the use of these models for inference in small datasets or when co-occurrence is expected to be weak, but show they are suitable to detect strong co-occurrence in larger datasets and generate predictions of site occupancy states.","NA","biorxiv",1727302158081
"snCED-seq: High-fidelity cryogenic enzymatic dissociation of nuclei for single-nucleus RNA-seq of FFPE tissues","10.1101/2024.09.20.614201","biorxiv",2.35,2.35,2.35,2.35,2.35,"yunxia, G.; Junjie, M.; Ruicheng, Q.; Wang, G.-Z.; Zhao, X.","Xiangwei Zhao","State Key Laboratory of Digital Medical Engineering, School of Biological Science & Medical Engineering, Southeast University, Nanjing 210096, China","2024-09-24","1","new results","cc_no","bioengineering","https://www.biorxiv.org/content/early/2024/09/24/2024.09.20.614201.source.xml","Profiling cellular heterogeneity in formalin-fixed paraffin-embedded (FFPE) tissues is key to characterizing clinical specimens for biomarkers, therapeutic targets, and drug responses. Recent advancements in single-nucleus RNA sequencing (snRNA-seq) techniques tailored for FFPE tissues have demonstrated their feasibility. However, isolation of high-quality nuclei from FFPE tissue with current methods remains challenging due to RNA cross-linking. We, therefore, proposed a novel strategy for the preparation of high-fidelity nuclei from FFPE samples, cryogenic enzymatic dissociation (CED) method, and performed snRandom-seq (snCED-seq) for polyformaldehyde (PFA) -fixed and FFPE brains to verify its applicability. The method is compatible with both PFA-based and FFPE brains or other organs with less hands-on time and lower reagent costs, and produced 10 times more nuclei than the homogenate method, without secondary degradation of RNA, and maximized the retention of RNA molecules within nuclei. snCED-seq shows 1.5-2 times gene and UMI numbers per nucleus, higher gene detection sensitivity and RNA coverage, and a minor rate of mitochondrial and ribosomal genes, compared with the nuclei from traditional method. The correlation gene expression of nucleus from the post-fixed and the frozen sample can be up to 94 %, and the gene expression of our nuclei was more abundant. Moreover, we applied snCED-seq to cellular heterogeneity study of the specimen on Alzheimer's Disease (AD) to demonstrate a pilot application. Scarce Cajal Retzius cells in older mice were robustly detected in our data, and we successfully identified two subpopulations of disease-associated in astrocytes, microglia and oligodendrocytes, respectively. Meanwhile, we found that most cell types are affected at the transcriptional level by AD pathology, and there is a disease susceptibility gene set that affects these cell types similarly. Our method provides powerful nuclei for snRNA-seq studies for FFPE specimens, and even helps to reveal multi-omics information of clinical samples.","NA","biorxiv",1727302158081
"Phonological decoding ability is associated with fiber density of the left arcuate fasciculus longitudinally across reading development","10.1101/2024.09.24.614799","biorxiv",2.35,2.35,2.35,2.35,2.35,"Perdue, M. V.; Geeraert, B. L.; Manning, K. Y.; Dewey, D.; Lebel, C.","Meaghan V Perdue","University of Calgary","2024-09-24","1","new results","cc_by_nc_nd","neuroscience","https://www.biorxiv.org/content/early/2024/09/24/2024.09.24.614799.source.xml","Numerous studies have linked reading ability to white matter microstructure using diffusion tensor imaging, but recent large studies have failed to show consistency. Fiber-specific diffusion-weighted magnetic resonance imaging (dMRI) models offer enhanced precision to measure specific features of white matter structure and may be more sensitive to individual differences in reading skills. However, fiber-specific models have not yet been applied to examine associations between reading ability and white matter microstructure over the course of reading acquisition. In this accelerated longitudinal study, we applied constrained spherical deconvolution (CSD) and fiber-specific modelling to characterize developmental changes in fiber density of key white matter tracts of the reading network bilaterally, and investigated associations between tract-wise fiber density and children's phonological decoding abilities. Fiber density was measured from ages 2-13 years, and decoding ability (pseudoword reading) was assessed at ages 6 years and older. Higher decoding ability was associated with greater fiber density in the left arcuate fasciculus, and effects remained consistent over time. Follow-up analysis revealed that asymmetry changes in the arcuate fasciculus were moderated by decoding ability: good decoders showed leftward asymmetry from early childhood onward, while poorer decoders shifted toward leftward asymmetry over time. These results suggest that densely organized fibers in the left arcuate fasciculus serve as a foundation for the development of reading skills from the pre-reading stage through fluent reading. Ongoing developmental changes in fiber density and microstructural asymmetry throughout childhood may reflect a reciprocal relationship in which reading experience continues to refine and strengthen these pathways.","NA","biorxiv",1727302158081
"Why do we have so many excitatory neurons?","10.1101/2024.09.24.614724","biorxiv",2.35,2.35,2.35,2.35,2.35,"Wang, Q.; Cardona, A.; Zlatic, M.; Vogelstein, J.; Priebe, C.","Qingyang Wang","Johns Hopkins University","2024-09-24","1","new results","cc_by_nc_nd","neuroscience","https://www.biorxiv.org/content/early/2024/09/24/2024.09.24.614724.source.xml","Approximately four in five neurons are excitatory. This is true across functional regions and species. Why do we have so many excitatory neurons? Little is known. Here we provide a normative answer to this question. We designed a task-agnostic, learning-independent and experiment-testable measurement of functional complexity, which quantifies the network's ability to solve complex problems. Using the first neuron level full connectome of a species - the larva Drosophila - we discovered the optimal Excitatory-Inhibitory (E-I) ratio that maximizes the functional complexity: 75-81% percentage of neurons are excitatory. This number is consistent with the true distribution observed via scRNA-seq. We found that the abundance of excitatory neurons confers an advantage in functional complexity, but only when inhibitory neurons are highly connected. In contrast, when the E-I identities are sampled uniformly (not dependent on connectivity), the optimal E-I ratio falls around equal population size, and its overall achieved functional complexity is sub-optimal. Our functional complexity measurement offers a normative explanation for the over-abundance of excitatory neurons in the brain. We anticipate that this approach will further uncover the functional significance of various neural network structures.","NA","biorxiv",1727302158081
"LLPS REDIFINE allows the biophysical characterization of multicomponent condensates without tags or labels","10.1101/2024.09.10.612223","biorxiv",2.35,2.35,2.35,2.35,2.35,"Novakovic, M.; Han, N.; Kathe, N. C.; Ni, Y.; Emmanouilidis, L.; Allain, F. H.- T.","Frederic H.-T. Allain","ETH Zurich","2024-09-10","1","new results","cc_no","biophysics","https://www.biorxiv.org/content/early/2024/09/10/2024.09.10.612223.source.xml","Liquid-liquid phase separation (LLPS) phenomenon plays a vital role in multiple cell biology processes, providing a mechanism to concentrate biomolecules and promote cellular reactions locally. Despite its significance in biology, there is a lack of conventional techniques suitable for studying biphasic samples in their biologically relevant form. Here, we present a label-free and non-invasive approach to characterize protein, RNA and water in biomolecular condensates termed LLPS REstricted DIFusion of INvisible speciEs (REDIFINE). Relying on diffusion NMR measurements, REDIFINE exploits the exchange dynamics between the condensed and dispersed phases to allow the determination of not only diffusion constants in both phases but also the fractions of the species, the average radius of the condensed droplets and the exchange rate between the phases. We can also access the concentration of proteins in both phases. Observing proteins, RNAs, water, and even small molecules, REDIFINE analysis allows a rapid biophysical characterization of multicomponent condensates which is important to understand their functional roles. In comparing multiple systems, REDIFINE reveals that folded RNA-binding proteins form smaller and more dynamic droplets compared to the disordered ones. In addition, REDIFINE proved to be valuable beyond LLPS for the determination of binding constants in soluble protein-RNA without the need for titration.","NA","biorxiv",1727302158081
"From spots to cells: Cell segmentation in spatial transcriptomics with BOMS","10.1101/2024.09.21.614281","biorxiv",2.25,2.25,2.25,2.25,2.25,"Kamboj, O.; Park, J.; Stegle, O.; Hamprecht, F. A.","Fred  A. Hamprecht","Heidelberg University","2024-09-24","1","new results","cc_by","genomics","https://www.biorxiv.org/content/early/2024/09/24/2024.09.21.614281.source.xml","Imaging-based Spatial Transcriptomics methods enable the study of gene expression and regulation in complex tissues at subcellular resolution. However, inaccurate cell segmentation procedures lead to misassignment of mRNAs to individual cells which can introduce errors in downstream analysis. Current methods estimate cell boundaries using auxiliary DAPI/Poly(A) stains. These stains can be difficult to segment, thus requiring manual tuning of the method, and not all mRNA molecules may be assigned to the correct cells. We describe a new method, based on mean shift, that segments the cells based on the spatial locations and the gene labels of the mRNA spots without requiring any auxiliary images. We evaluate the performance of BOMS across various publicly available datasets and demonstrate that it achieves comparable results to the best existing method while being simple to implement and significantly faster in execution. Open-source code is available at https://github.com/sciai-lab/boms.","NA","biorxiv",1727302158081
"Fine-tuning sequence-to-expression models onpersonal genome and transcriptome data","10.1101/2024.09.23.614632","biorxiv",2.2,2.2,2.2,2.2,2.2,"Rastogi, R.; Reddy, A. J.; Chung, R.; Ioannidis, N. M.","Nilah M. Ioannidis","University of California, Berkeley","2024-09-25","1","new results","cc_by_nc_nd","genomics","https://www.biorxiv.org/content/early/2024/09/25/2024.09.23.614632.source.xml","Genomic sequence-to-expression deep learning models, which are trained to predict gene expression and other molecular phenotypes across the reference genome, have recently been shown to have poor out-of-the-box performance in predicting gene expression variation across individuals based on their personal genome sequences. Here we explore whether additional training (fine-tuning) on paired personal genome and transcriptome data improves the performance of such sequence-to-expression models. Using Enformer as a representative pre-trained model, we explore various fine-tuning strategies. Our results show that fine-tuning improves cross-individual prediction performance over the baseline Enformer model for held-out individuals on genes seen during fine-tuning, with comparable performance to variant-based linear models commonly used in transcriptome-wide association studies. However, fine-tuning does not improve model generalizability on held-out genes, which contain sequences and variants unseen during fine-tuning, highlighting a remaining open challenge in the field.","NA","biorxiv",1727302158081
"Mimicking mechanics: A comparison of meat and meat analogs","10.1101/2024.09.23.614641","biorxiv",2.2,2.2,2.2,2.2,2.2,"St. Pierre, S. R.; Kuhl, E.","Ellen Kuhl","Stanford University","2024-09-24","1","new results","cc_by","bioengineering","https://www.biorxiv.org/content/early/2024/09/24/2024.09.23.614641.source.xml","The texture of meat is one of the most important features to mimic when developing meat analogs. Both protein source and processing method impact the texture of the final product. We can distinguish three types of mechanical tests to quantify the textural differences between meat and meat analogs: puncture-type, rheological torsion tests, and classical mechanical tests of tension, compression, and bending. Here we compile the shear force and stiffness values of whole and comminuted meats and meat analogs from the two most popular tests for meat, the Warner-Bratzler shear test and the double-compression texture profile analysis. Our results suggest that, with the right fine-tuning, today's meat analogs are well capable of mimicking the mechanics of real meat. While Warner-Bratzler shear tests and texture profile analysis provide valuable information about the tenderness and sensory perception of meat, both tests suffer from a lack of standardization, which limits cross-study comparisons. Here we provide guidelines to standardize meat testing and report the meat stiffness as the single most informative mechanical parameter. Collecting big standardized data and sharing them with the community at large could empower researchers to harness the power of generative artificial intelligence to inform the systematic development of meat analogs with desired mechanical properties and functions, taste and sensory perception.","NA","biorxiv",1727302158081
"Joint Modeling of Cellular Heterogeneity and Condition Effects with scPCA in Single-Cell RNA-Seq","10.1101/2024.09.22.614322","biorxiv",2.1,2.1,2.1,2.1,2.1,"Vohringer, H. S.; Huber, W.; Dietrich, S.","Harald Sager Vohringer","Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg; Department of Hematology and Oncology, University H","2024-09-24","1","new results","cc_by_nc_nd","bioinformatics","https://www.biorxiv.org/content/early/2024/09/24/2024.09.22.614322.source.xml","Single-cell RNA sequencing (scRNA-seq) in multi-condition experiments enables the systematic assessment of treatment effects. Analyzing scRNA-seq data relies on linear dimensionality reduction (DR) methods like principal component analysis (PCA). These methods decompose high-dimensional gene expression profiles into tractable factor representations and prototypical gene expression patterns (components), facilitating the study of cell type variation. However, integrating study covariates within linear DR frameworks remains a challenging task. We present scPCA, a flexible DR framework that jointly models cellular heterogeneity and conditioning variables, allowing it to recover an integrated factor representation and reveal transcriptional changes across conditions and components of the decomposition. We show that scPCA extracts an interpretable latent representation by analyzing unstimulated and IFN-beta-treated PBMCs, and showcase that the model may be employed to effectively address batch effects. We examine age-related changes in rodent lung cell populations, uncovering a previously unreported surge in Ccl5 expression in T cells. We illustrate how scPCA may be employed to identify coordinated transcriptional changes across multiple time-points in depolarized visual cortex neurons. Finally, we show that scPCA elucidates transcriptional shifts in CRISPR-Cas9 chordin knockout zebrafish fish single-cell data despite large difference cell abundance across conditions. Since scPCA introduces a general approach to account for conditioning variables in high-dimensional data, it may also be applicable to datasets other than scRNA-seq.","NA","biorxiv",1727302158081
"Independent evolution of ipecac alkaloid biosynthesis","10.1101/2024.09.23.614470","biorxiv",2.1,2.1,2.1,2.1,2.1,"Colinas, M.; Morweiser, C.; Dittberner, O.; Chioca, B.; Alam, R.; Leucke, H.; Nakamura, Y.; Serna Guerrero, D. A.; Heinicke, S.; Kunert, M.; Wurlitzer, J.; Ploss, K.; Hong, B.; Grabe, V.; Lopes, A. A.; O'Connor, S. E.","Maite Colinas","Max Planck Institute for Chemical Ecology","2024-09-25","1","new results","cc_no","plant biology","https://www.biorxiv.org/content/early/2024/09/25/2024.09.23.614470.source.xml","Ipecac alkaloids are medicinal monoterpenoid-derived tetrahydroisoquinoline alkaloids found in two distantly related plants: Carapichea ipecacuanha (Gentianales) and Alangium salviifolium (Cornales). We have elucidated ipecac alkaloid biosynthesis in both species, conclusively demonstrating that biosynthesis of the structurally complex ipecac alkaloid protoemetine has evolved independently. We show that although protoemetine biosynthesis proceeds via the same chemical logic in both species, each plant uses a distinct monoterpene precursor. Moreover, we provide evidence that both plants initiate ipecac biosynthesis by a non-enzymatic Pictet-Spengler reaction, and we elucidate the biosynthetic fate of both the 1R and 1S stereoisomers that are produced in this non-stereoselective reaction. Phylogenetic analyses clearly show independent pathway evolution through parallel and convergently evolved enzymes. This work provides insight into how nature can capitalize on highly reactive starting substrates, the manner in which multi-step pathways can arise, and also lays the foundation for metabolic engineering of these important medicinal compounds.","NA","biorxiv",1727302158081
"Quantitative Comparison of Monomeric StayGold Variants Using Protein Nanocages in Living Cells","10.1101/2024.09.16.613379","biorxiv",2,2,2,2,2,"Viola, G.; Jacobs, K. A.; Lemiere, J.; Kutys, M. L.; Wittmann, T.","Torsten Wittmann","University of California, San Francisco","2024-09-17","1","new results","cc_by_nc_nd","cell biology","https://www.biorxiv.org/content/early/2024/09/17/2024.09.16.613379.source.xml","To standardize comparison of fluorescent proteins and independently determine which monomeric StayGold variant is best for live microscopy, we analyzed fluorescent protein tagged I3-01 peptides that self-assemble into stable sixty subunit dodecahedrons inside live cells. We find mStayGold is 3-fold brighter and 3-fold more photostable compared with EGFP and superior to other monomeric variants in mammalian cytoplasm. In addition, analysis of intracellular nanocage diffusion confirms the monomeric nature of mStayGold.","NA","biorxiv",1727302158081
"Galvanin is an electric-field sensor for directed cell migration","10.1101/2024.09.23.614580","biorxiv",2,2,2,2,2,"Belliveau, N. M.; Footer, M. J.; Platenkamp, A.; Kim, H.; Eustis, T. E.; Theriot, J. A.","Julie A. Theriot","University of Washington","2024-09-24","1","new results","cc_by","cell biology","https://www.biorxiv.org/content/early/2024/09/24/2024.09.23.614580.source.xml","Directed cell migration is critical for the rapid response of immune cells, such as neutrophils, following tissue injury or infection. Endogenous electric fields, generated by the disruption of the transepithelial potential across the skin, help to guide the movement of immune and skin cells toward the wound site. However, the mechanisms by which cells sense these physical cues remain largely unknown. Through a CRISPR-based screen, we identified Galvanin, a previously uncharacterized single-pass transmembrane protein that is required for human neutrophils to change their direction of migration in response to an applied electric field. Our results indicate that Galvanin rapidly relocalizes to the anodal side of a cell on exposure to an electric field, and that the net charge on its extracellular domain is necessary and sufficient to drive this relocalization. The spatial pattern of neutrophil protrusion and retraction changes immediately upon Galvanin relocalization, suggesting that it acts as a direct sensor of the electric field that then transduces spatial information about a cell's electrical environment to the migratory apparatus. The apparent mechanism of cell steering by sensor relocalization represents a new paradigm for directed cell migration.","NA","biorxiv",1727302158081
"Implementing portable, real-time 16S rRNA sequencing in the healthcare sector enhances antimicrobial stewardship","10.1101/2024.09.23.24314079","medrxiv",2,2,2,2,2,"Carlisle, D.; Cunningham-Oakes, E.; Booth, J.; Frankland, A.; McDowell, M.; Pilgrim, J.; Rzeszutek, A.; Evans, C.; Larkin, S.; Li, A.; Loftus, C.; Samuel, M.; Scott, N.; Swithenbank, L.; Owen, V.; Darby, A. C.; Smielewska, A.","Anna Smielewska","Liverpool Clinical Laboratories, CSSB, Liverpool, United Kingdom; Department of Infection Biology and Microbiomes, Institute of Infection, Institute of Veterina","2024-09-25","2","PUBLISHAHEADOFPRINT","cc_no","infectious diseases","https://www.medrxiv.org/content/early/2024/09/25/2024.09.23.24314079.source.xml","Background Antimicrobial resistance (AMR) poses a significant global health challenge, resulting in over 1.27 million deaths in 2019 and projected to cause up to 10 million deaths annually in the future. To address this issue, the healthcare sector requires rapid and accurate bacterial identification, which is currently not readily available for effective antimicrobial stewardship. In a UK national first, we implemented 16S ribosomal RNA (rRNA) sequencing using Oxford Nanopore Technology (ONT) in an NHS setting to enhance diagnostic capabilities, aiming to reduce antibiotic misuse and improve patient outcomes. Methods We implemented 16S rRNA sequencing via ONT, running samples from seven NHS hospitals across Cheshire and Merseyside. We focused on samples from sterile sites, such as 'pus', 'fluid', and 'tissue', typically collected from critical care units. The assay was validated against traditional methods including Sanger sequencing and MALDI-TOF, with a turnaround time of 24-72 hours. Clinical impact was measured by analysing changes in antibiotic regimens and patient outcomes based on 16S assay results over a period of several months post-launch. Findings ONT 16S rRNA sequencing significantly impacted antibiotic treatment in 34.2% of cases, reducing patient stays and outperforming traditional methods by detecting additional bacterial organisms and identifying bacteria missed by reference labs. It provided species-level identification and confirmed non-infectious conditions in 5.4% of cases, aiding alternative treatment decisions. Its speed, cost-effectiveness, and minimal training requirements contributed to its successful integration into clinical practice. Interpretation The integration of ONT 16S sequencing into routine NHS diagnostics has significantly improved antimicrobial stewardship by offering a faster, more sensitive, and accurate bacterial identification method. Earlier use of this assay in cases where routine cultures are likely to fail could enhance patient outcomes further by enabling timely, targeted antibiotic therapies, reducing hospital stays, and curbing unnecessary antibiotic use.","NA","medrxiv",1727302158081
"Harnessing multi-output machine learning approach and dynamical observables from network structure to optimize COVID-19 intervention strategies","10.1101/2024.09.23.24313636","medrxiv",2,2,2,2,2,"Alves, C.; Kuhnert, K.; Rodrigues, F. A.; Moeckel, M.","Caroline Alves","Aschaffenburg University of applied sciences","2024-09-24","1","PUBLISHAHEADOFPRINT","cc_no","epidemiology","https://www.medrxiv.org/content/early/2024/09/24/2024.09.23.24313636.source.xml","The COVID-19 pandemic has necessitated the development of accurate models to predict disease dynamics and guide public health interventions. This study leverages the COVASIM agent-based model to simulate 1331 scenarios of COVID-19 transmission across various social settings, focusing on the school, community, and work contact layers. We extracted complex network measures from these simulations and applied deep learning algorithms to predict key epidemiological outcomes, such as infected, severe, and critical cases. Our approach achieved an R2 value exceeding 95%, demonstrating the model's robust predictive capability. Additionally, we identified optimal intervention strategies using spline interpolation, revealing the critical roles of community and workplace interventions in minimizing the pandemic's impact. The findings underscore the value of integrating network analytics with deep learning to streamline epidemic modeling, reduce computational costs, and enhance public health decision-making. This research offers a novel framework for effectively managing infectious disease outbreaks through targeted, data-driven interventions.","NA","medrxiv",1727302158081
"Ancestry and somatic profile predict acral melanoma origin and prognosis","10.1101/2024.09.21.24313911","medrxiv",2.5,2,2.5,2.5,2.5,"Basurto-Lozada, P.; Vazquez-Cruz, M. E.; Molina-Aguilar, C.; Jiang, A.; Deacon, D. C.; Cerrato-Izaguirre, D.; Simonin-Wilmer, I.; Arriaga-Gonzalez, F. G.; Contreras-Ramirez, K. L.; Dawson, E. T.; Wong-Ramirez, J. R. C.; Ramos-Galguera, J. I.; Alvarez-Cano, A.; Garcia-Ortega, D. Y.; Garcia-Salinas, O. I.; Hidalgo-Miranda, A.; Cisneros-Villanueva, M.; Martinez-Said, H.; Arends, M. J.; Ferreira, I.; Tullett, M.; Olvera-Leon, R.; van der Weyden, L.; Del Castillo Velasco-Herrera, M.; Roldan-Marin, R.; Vidaurri de la Cruz, H.; Tavares-de-la-Paz, L. A.; Hinojosa-Ugarte, D.; Belote, R. L.; Bishop, D. ","Carla Daniela Robles-Espinoza","Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico, 76230","2024-09-24","1","PUBLISHAHEADOFPRINT","cc_by_nd","genetic and genomic medicine","https://www.medrxiv.org/content/early/2024/09/24/2024.09.21.24313911.source.xml","Acral melanoma, which is not ultraviolet (UV)-associated, is the most common type of melanoma in several low- and middle-income countries including Mexico. Latin American samples are significantly underrepresented in global cancer genomics studies, which directly affects patients in these regions as it is known that cancer risk and incidence may be influenced by ancestry and environmental exposures. To address this, here we characterise the genome and transcriptome of 128 acral melanoma tumours from 96 Mexican patients, a population notable because of its genetic admixture. Compared with other studies of melanoma, we found fewer frequent mutations in classical driver genes such as BRAF, NRAS or NF1. While most patients had predominantly Amerindian genetic ancestry, those with higher European ancestry had increased frequency of BRAF mutations and a lower number of structural variants. These BRAF-mutated tumours have a transcriptional profile similar to cutaneous non-volar melanocytes, suggesting that acral melanomas in these patients may arise from a distinct cell of origin compared to other tumours arising in these locations. KIT mutations were found in a subset of these tumours, and transcriptional profiling defined three expression clusters; these characteristics were associated with overall survival. We highlight novel low-frequency drivers, such as SPHKAP, which correlate with a distinct genomic profile and clinical characteristics. Our study enhances knowledge of this understudied disease and underscores the importance of including samples from diverse ancestries in cancer genomics studies.","NA","medrxiv",1727302158081
"Emergence to dominance: Estimating time to dominance of SARS-CoV-2 variants using nonlinear statistical models","10.1101/2024.09.21.24314137","medrxiv",2.25,2,2.25,2.25,2.25,"Awasthi, S.; Zolfaghari Dehkharghani, M.; Fudolig, M.","Miguel Fudolig","University of Nevada Las Vegas","2024-09-23","1","PUBLISHAHEADOFPRINT","cc_by","epidemiology","https://www.medrxiv.org/content/early/2024/09/23/2024.09.21.24314137.source.xml","Background/Objective: Relative proportion of cases in a multi-strain pandemic like the COVID-19 pandemic provides insight on how fast a newly emergent variant dominates the infected population. However, the behavior of relative proportion of emerging variants is an understudied field. We investigated the emerging behavior of dominant COVID-19 variants using nonlinear statistical methods and calculated the time to dominance of each variant. Method: We used a phenomenological approach to model national- and regional-level variant share data from the national genomic surveillance system provided by the Centers for Disease Control and Prevention to determine the best model to describe the emergence of two recent dominant variants of the SARS-CoV-2 virus: XBB.1.5 and JN.1. The proportions were modeled using logistic, Weibull, and generalized additive models. Model performance was evaluated using the Akaike Information Criteria (AIC) and the root mean square error (RMSE).  Findings: The Weibull model performed the worst out of all three approaches. The generalized additive model approach slightly outperformed the logistic model based on fit statistics, but lacked in interpretability compared to the logistic model. These models were then used to estimate the time elapsed from emergence to dominance in the infected population, denoted by the time to dominance (TTD). All three models yielded similar TTD estimates. The XBB.1.5 variant was found to dominate the population faster compared to the JN.1 variant, especially in HHS Region 2 (New York) where the XBB.1.5 was believed to emerge. This research expounds on how emerging viral strains transition to dominance, informing public health interventions against future emergent COVID-19 variants and other infectious diseases.","NA","medrxiv",1727302158081
"Neuroinvasive and neurovirulent potential of SARS-CoV-2 in the acute and post-acute phase of intranasally inoculated ferrets","10.1101/2024.09.21.614276","biorxiv",1.9500000000000002,1.9500000000000002,1.9500000000000002,1.9500000000000002,1.9500000000000002,"Benavides, F. F. W.; Kroeze, E. J. B. V.; Leijten, L. M.; Schmitz, K. S.; van Run, P.; Kuiken, T.; de Vries, R. D.; Bauer, L.; van Riel, D.","Debby van Riel","Erasmus Medical Center","2024-09-23","1","new results","cc_by","microbiology","https://www.biorxiv.org/content/early/2024/09/23/2024.09.21.614276.source.xml","Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) can cause systemic disease, including neurological complications, even after mild respiratory disease. Previous studies have shown that SARS-CoV-2 infection can induce neurovirulence through microglial activation in the brains of patients and experimentally inoculated animals, which are models representative for moderate to severe respiratory disease. Here, we aimed to investigate the neuroinvasive and neurovirulent potential of SARS-CoV-2 in intranasally inoculated ferrets, a model for subclinical to mild respiratory disease. The presence of viral RNA, histological lesions, virus-infected cells, and the number and surface area of microglia and astrocytes were investigated. Viral RNA was detected in various respiratory tissue samples by qPCR at 7 days post inoculation (dpi). Virus antigen was detected in the nasal turbinates of ferrets sacrificed at 7 dpi and was associated with inflammation. Viral RNA was detected in the brains of ferrets sacrificed 7 dpi, but in situ hybridization nor immunohistochemistry did not verify evidence of infection.  Histopathological analysis of the brains showed no evidence for an influx of inflammatory cells. Despite this, we observed an increased number of Alzheimer type II astrocytes in the hindbrains of SARS-CoV-2 inoculated ferrets. Additionally, we detected an increased microglial activation in the olfactory bulb and hippocampus, and a decrease in the astrocytic activation status in the white matter and hippocampus of SARS-CoV-2 inoculated ferrets. In conclusion, although showed that SARS-CoV-2 has limited neuroinvasive potential in this model for subclinical to mild respiratory disease, there is evidence for neurovirulent potential. This study highlights the value of this ferret model to study the neuropathogenicity of SARS-CoV-2 and reveals that a mild SARS-CoV-2 infection can affect both microglia and astrocytes in different parts of the brain.","NA","biorxiv",1727302158081
"Ancient inversion polymorphisms are locally adaptive in a widespread butterfly species","10.1101/2024.09.20.614156","biorxiv",1.85,1.85,1.85,1.85,1.85,"Seixas, F. A.; Dendy, S.; Guan, S.; Rosser, N.; Grishin, N. V.; Davies, N.; Gilbert, L. E.; McMillan, O. W.; Mallet, J.","Fernando A. Seixas","Harvard University","2024-09-24","1","new results","cc_by_nc_nd","evolutionary biology","https://www.biorxiv.org/content/early/2024/09/24/2024.09.20.614156.source.xml","Wide-ranging species are subject to varying biotic and abiotic selection pressures across their distribution. While local adaptation does not manifest in obvious morphological changes, population genomic studies can reveal cryptic diversity and provide insights into local adaptive processes. In this study, we investigated the biogeographic history and genomic diversity across the range of the zebra longwing butterfly Heliconius charithonia, a species with a widespread distribution in the Neotropics, but which is phenotypically homogenous across its range. We examined whole genome sequence data from 55 individuals from the eight described subspecies. We infer that there were at least two distinct colonization events of the Caribbean islands from the mainland. The second colonization wave occurred relatively recently, accounting for the genetic homogeneity observed across the species' range. Despite low divergence across most of the genome, two large non-recombining genomic regions showed deeply divergent haplotypes that correspond to chromosomal inversions. Phylogenetic analyses indicate ancient origins of these inversion polymorphisms, and there is no evidence that they were introgressed from another extant lineage of Heliconius. These ancient polymorphisms are likely maintained by heterogeneous selection across the landscape, with the inversion on chromosome 19 likely playing a role in local adaptation to cold and desiccation. Our findings underscore the importance of genomic analysis in uncovering hidden diversity and adaptation in phenotypically homogenous species and highlight the significant role of chromosomal inversions in driving local adaptation.","NA","biorxiv",1727302158081
"Engineering CD3 Subunits with Endoplasmic Reticulum Retention Signal Facilitates Allogeneic CAR T Cell Production","10.1101/2024.09.22.614328","biorxiv",1.85,1.85,1.85,1.85,1.85,"Ebrahimiyan, H.; Sayadmanesh, A.; Hesaraki, M.; Ebrahimi, M.; Baharvand, H.; Basiri, M.","Mohsen Basiri","Royan Institute","2024-09-24","1","new results","cc_by_nc_nd","immunology","https://www.biorxiv.org/content/early/2024/09/24/2024.09.22.614328.source.xml","The success of autologous CAR T cell therapies has driven interest in developing off-the-shelf allogeneic CAR T cells as a scalable and readily available option for broader patient access. Most of the current approaches involve the knockout of T cell receptor (TCR) subunits via genome editing for preventing graft-versus-host disease (GvHD). However, clinical translation of these methods faces challenges due to manufacturing complexities and emerging safety concerns like unintended long deletions and chromosomal loss. In this study, we explored an alternative approach by engineering synthetic CD3 subunits containing an endoplasmic reticulum retention (ERR) signal to suppress TCR surface expression by disrupting its trafficking to the plasma membrane. We screened multiple CD3-ERR candidate designs to identify the construct with the highest efficacy in TCR downregulation. The selected candidate, CD3{zeta}-ERR, was further characterized, demonstrating its ability to minimize TCR-mediated activation and alloreactivity without affecting T cell phenotype, cell cycle and cytokine-induced expansion. Subsequent assays revealed that CD3{zeta}-ERR CD19 CAR T cells retained their CAR-mediated cytotoxic function against CD19+ malignant cells. This study presents an alternative approach for TCR downregulation that circumvents genome editing. By using a transgene compatible with conventional viral vector delivery, this approach holds promise for scalable clinical-grade manufacturing of allogeneic CAR T cell therapies.","NA","biorxiv",1727302158081
"Adaptation to space conditions of novel bacterial species isolated from the International Space Station revealed by functional gene annotations and comparative genome analysis","10.1101/2023.09.28.559980","biorxiv",47.5,0.5,39,39,46,"SZYDLOWSKI, L. M.; Bulbul, A.; Simpson, A. C.; Kaya, D. E.; Singh, N. K.; Sezerman, U. O.; Labaj, P. P.; Kosciolek, T.; Venkateswaran, K.","Kasthuri Venkateswaran","California Institute of Technology","2024-08-21","2","new results","cc_by_nc_nd","bioinformatics","https://www.biorxiv.org/content/early/2024/08/21/2023.09.28.559980.source.xml","BackgroundThe extreme environment of the International Space Station (ISS) puts selective pressure on microorganisms unintentionally introduced during its 20+ years of service as a low-orbit science platform and human habitat. Such pressure leads to the development of new features not found in the Earth-bound relatives, which enable them to adapt to unfavorable conditions.

ResultsIn this study, we generated the functional annotation of the genomes of five newly identified species of Gram-positive bacteria, four of which are non-spore-forming and one spore-forming, all isolated from the ISS. Using a deep-learning based tool - deepFRI - we were able to functionally annotate close to 100% of protein-coding genes in all studied species, overcoming other annotation tools. Our comparative genomic analysis highlights common characteristics across all five species and specific genetic traits that appear unique to these ISS microorganisms. Proteome analysis mirrored these genomic patterns, revealing similar traits. The collective annotations suggest adaptations to life in space, including the management of hypoosmotic stress related to microgravity via mechanosensitive channel proteins, increased DNA repair activity to counteract heightened radiation exposure, and the presence of mobile genetic elements enhancing metabolism. In addition, our findings suggest the evolution of certain genetic traits indicative of potential pathogenic capabilities, such as small molecule and peptide synthesis and ATP-dependent transporters. These traits, exclusive to the ISS microorganisms, further substantiate previous reports explaining why microbes exposed to space conditions demonstrate enhanced antibiotic resistance and pathogenicity.

ConclusionOur findings indicate that the microorganisms isolated from ISS we studied have adapted to life in space. Evidence such as mechanosensitive channel proteins, increased DNA repair activity, as well as metallopeptidases and novel S-layer oxidoreductases suggest a convergent adaptation among these diverse microorganisms, potentially complementing one another within the context of the microbiome. The common genes that facilitate adaptation to the ISS environment may enable bioproduction of essential biomolecules need during future space missions, or serve as potential drug targets, if these microorganisms pose health risks.","NA","biorxiv",1727302158081
"Neural emotion regulation during pregnancy - a fMRI study investigating a transdiagnostic mental health factor in healthy first-time pregnant women","10.1101/2024.09.13.24313410","medrxiv",28.25,0,22,26,28.25,"Weinmar, F.; Kogler, L.; Rehbein, E.; Morawetz, C.; Sundstroem-Poromaa, I.; Skalkidou, A.; Derntl, B.","Birgit Derntl","University of Tuebingen","2024-09-14","1","PUBLISHAHEADOFPRINT","cc_by","psychiatry and clinical psychology","https://www.medrxiv.org/content/early/2024/09/14/2024.09.13.24313410.source.xml","Pregnancy is a psycho-neuro-endocrinological transition phase in which a plethora of hormone levels rise substantially, modulating socioemotional functions, brain structures, and networks and thus presenting a window of vulnerability for mental health. A transdiagnostic factor for psychopathology is emotion regulation, which is influenced by sex hormones, such as estradiol (E2), across the menstrual cycle on the behavioral and neural level. Whether this is also the case in the antepartum period remains unknown. For the first time, behavioral and neural emotion regulation were investigated in healthy primiparous pregnant females with extremely high E2 levels during the second trimester (N = 15) using a functional magnetic resonance imaging (fMRI) paradigm. Results were compared with naturally-cycling females with high E2 levels (after E2-administration, N = 16) and low E2 levels (early follicular phase, N = 16). Although pregnant females reported the lowest trait use of cognitive reappraisal, all females successfully regulated their emotions by applying cognitive reappraisal in the scanner. On the neural level, all females had increased activity in the left middle frontal gyrus during downregulation of negative emotions. Pregnant females showed no significant differences in functional connectivity (psychophysiological interaction, resting-state) related to emotion regulation compared to the nonpregnant group. However, group differences emerged for amygdala activation. In pregnant females, increased amygdala activity predicted reduced regulation success and was positively associated with depression scores. This first fMRI study during pregnancy indicates that depression scores are reflected in heightened amygdala activity already observable in the antepartum period. Thus, through its association with reduced regulation success, increased amygdala activity suggests a neural risk marker for peripartum mental health. Future research needs to investigate emotion regulation in pregnant and postpartum women to further understand pregnancy-related changes and associations of mood, emotional and neural functions. Eventually, this will allow enhanced identification, prevention, and treatment of peri- and postpartum mental ill-health.","NA","medrxiv",1727302158081
"Architectural immunity: ants alter their nest networks to prevent epidemics","10.1101/2024.08.30.610481","biorxiv",53.33,0,18,25,53.33,"Leckie, L.; Andon, M. S.; Bruce, K.; Stroeymeyt, N.","Nathalie Stroeymeyt","University of Bristol","2024-09-02","1","new results","cc_by_nc","animal behavior and cognition","https://www.biorxiv.org/content/early/2024/09/02/2024.08.30.610481.source.xml","In animal groups, spatial heterogeneities shape social contact networks, thereby influencing the transmission of infectious diseases. Active modifications to the spatial environment could thus be a potent tool to mitigate epidemic risk. We tested whether Lasius niger ants modify their nest architecture in response to pathogens by introducing controlor pathogen-treated individuals into nest-digging groups, and monitoring three-dimensional nest morphogenesis over time. Pathogen exposure led to an array of architectural changes including faster nest growth, increased spacing between entrances, transmission-inhibitory changes in overall nest network topology, and reduced chamber centrality. Simulations confirmed that these changes reduced disease spread. These results provide evidence for architectural immunity in a social animal and offer insights into how spatial organisation can be leveraged to decrease epidemic susceptibility.","NA","biorxiv",1727302158081
"The Greenland shark (Somniosus microcephalus) genome provides insights into extremelongevity","10.1101/2024.09.09.611499","biorxiv",75.58,0.5,17.5,17.5,75.58,"Sahm, A.; Cherkasov, A.; Liu, H.; Voronov, D.; Siniuk, K.; Schwarz, R.; Ohlenschlaeger, O.; Foerste, S.; Bens, M.; Groth, M.; Goerlich, I.; Paturej, S.; Klages, S.; Braendl, B.; Olsen, J.; Bushnell, P.; Poulsen, A. B.; Ferrando, S.; Garibaldi, F.; Drago, D. L.; Tozzini, E. T.; Mueller, F.-J.; Fischer, M.; Kretzmer, H.; Domenici, P.; Steffensen, J. F.; Cellerino, A.; Hoffmann, S.","Steve Hoffmann","Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)","2024-09-10","1","new results","cc_by","genomics","https://www.biorxiv.org/content/early/2024/09/10/2024.09.09.611499.source.xml","The Greenland shark (Somniosus microcephalus) is the longest-lived vertebrate known, with an estimated lifespan of [~] 400 years. Here, we present a chromosome-level assembly of the 6.45 Gb Greenland shark, rendering it one of the largest non-tetrapod genomes sequenced so far. Expansion of the genome is mostly accounted for by a substantial expansion of transposable elements. Using public shark genomes as a comparison, we found that genes specifically duplicated in the Greenland shark form a functionally connected network enriched for DNA repair function. Furthermore, we identified a unique insertion in the conserved C-terminal region of the key tumor suppressor p53. We also provide a public browser to explore its genome.","NA","biorxiv",1727302158081
"Inhibition of HIF-2 Pathway as a Potential Therapeutic Strategy for Endothelial Dysfunction in Post-COVID Syndrome","10.1101/2024.09.10.24313403","medrxiv",302.9,0.5,15.799999999999997,22.050000000000004,302.9,"Kuchler, T.; Ribeiro, A.; Lech, M.; Carbajo-Lozoya, J.; Adorjan, K.; Stubbe, H. C.; Seifert, M.; Wohnle, A.; Kessler, V.; Negele, J.; Heemann, U.; Schmaderer, C.","Timon Kuchler","Technical University Munich, Klinikum rechts der Isar","2024-09-11","1","PUBLISHAHEADOFPRINT","cc_no","infectious diseases","https://www.medrxiv.org/content/early/2024/09/11/2024.09.10.24313403.source.xml","BackgroundSARS-CoV-2 infection may lead to Post-COVID Syndrome (PCS), characterized by debilitating symptoms like persistent fatigue, cardiovascular symptoms, and cognitive dysfunction. Persistent endothelial dysfunction (ED) is a potential driver of ongoing symptoms. Yet, the underlying biological mechanisms remain unclear.

MethodsIn this prospective observational study, we characterized 41 PCS patients and 24 healthy controls (HC, matched out of n = 204, recruited before the pandemic) and investigated the effect of SARS-CoV-2 Spike protein 1 (S1) and plasma from PCS patients on human retinal endothelial cells (HREC).

ResultsPlasma samples from PCS patients exhibited significantly elevated erythropoietin, VEGF and MCP-1 alongside decreased IL-6 levels compared to HC. Low Haemoglobin and Haematocrit were negatively associated with PCS severity. VEGF levels were positively correlated with Anti-S1 IgG levels in patients and upregulated on mRNA level in HREC exposed to S1. Additionally, S1 exposure promoted ROS production and transiently activated HIF-1 in HREC. Persistent activation of HIF-2 by S1 led to disrupted endothelial integrity. HREC exposed to plasma from severely affected PCS patients showed increased ROS and compromised barrier function. Treatment with Belzutifan, a HIF-2 inhibitor, restored barrier integrity in HREC exposed to S1 or PCS-plasma.

ConclusionThese findings suggest that HIF-2-mediated ED in PCS might be a potential therapeutical target for Belzutifan.

Trial registrationURL: https://www.clinicaltrials.gov; Unique identifier: NCT05635552

Novelty and significanceO_ST_ABSWhat Is Known?C_ST_ABSO_LIEndothelial dysfunction (ED) is a consequence of acute SARS-CoV-2 infection and may lead to Post-COVID syndrome (PCS) symptoms.
C_LIO_LIPatients with PCS show elevated inflammation and endothelial dysfunction markers.
C_LIO_LISpike proteins can persist for up to 12 months post-infection, driving ongoing inflammation and immune activation.
C_LI

What New Information Does This Article Contribute?O_LILow haemoglobin (Hb) and high VEGF correlate with higher Anti-S1 IgG and low Hb is associated with higher C19-YRS severity score.
C_LIO_LIPCS patients exhibit higher Erythropoietin (EPO) levels when compared to HC.
C_LIO_LISpike protein 1 (S1) alone and PCS patients plasma induce endothelial dysfunction primarily through HIF-2 activation.
C_LIO_LIBoth S1 and PCS plasma cause oxidative stress and disrupting endothelial integrity.
C_LIO_LIInhibition of HIF-2 effectively restores endothelial barrier integrity disrupted by S1 and PCS plasma.
C_LI

Persistent circulation of spike proteins can sustain chronic inflammation and immune activation in patients with PCS. Here we show that plasma from PCS patients exhibits significantly elevated levels of VEGF which positively correlates with Anti-S1 IgG. Low haemoglobin was associated with higher Anti-S1 IgG titres and correlated with a higher C19-YRS severity score. Levels of EPO were higher in PCS patients, with a more pronounced effect observed in patients with cardiovascular symptoms. In human retinal endothelial cells, both S1 and plasma from PCS patients primarily induce ED through HIF-2 activation, rather than NF-{kappa}B. Both factors lead to significant oxidative stress, evidenced by increased ROS production which in turn disrupts endothelial barrier integrity and function. Notably, Belzutifan, a HIF-2 inhibitor, can restore this compromised endothelial function, offering a potential therapeutic target for PCS.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=143 SRC=""FIGDIR/small/24313403v1_ufig1.gif"" ALT=""Figure 1"">
View larger version (35K):
org.highwire.dtl.DTLVardef@19df9e4org.highwire.dtl.DTLVardef@80eba4org.highwire.dtl.DTLVardef@1ee6680org.highwire.dtl.DTLVardef@8b6bd3_HPS_FORMAT_FIGEXP  M_FIG C_FIG","NA","medrxiv",1727302158081
"Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair for somatic benchmarks","10.1101/2024.09.18.613544","biorxiv",15.549999999999999,0.5,15.549999999999999,15.549999999999999,15.549999999999999,"McDaniel, J. H.; Patel, V.; Olson, N. D.; He, H.-J.; He, Z.; Schmitt, A.; Sikkink, K.; Sedlazeck, F.; Doddapaneni, H.; Jhangiani, S. N.; Muzny, D. M.; Gingras, M.-C.; Mehta, H.; Paulin, L. F.; Hastie, A. R.; Yu, H.-C.; Weigman, V.; Rojas, A.; Kennedy, K.; Remington, J.; Gonzalez, I.; Sudkamp, M.; Wiseman, K.; Lajoie, B.; Levy, S.; Jain, M.; Akeson, S.; Narzisi, G.; Steinsnyder, Z.; Reeves, C.; Shelton, J.; Kingan, S. B.; Lambert, C.; Bayabyan, P.; Wenger, A. M.; McLaughlin, I. J.; Adamson, A.; Kingsley, C.; Wescott, M.; Kim, Y.; Paten, B.; Park, J.; Violich, I.; Miga, K. H.; Gardner, J.; McNul","Jennifer H. McDaniel","The National Institute of Standards and Technology (NIST), Material Measurement Laboratory","2024-09-22","1","new results","cc0","genomics","https://www.biorxiv.org/content/early/2024/09/22/2024.09.18.613544.source.xml","The Genome in a Bottle Consortium (GIAB), hosted by the National Institute of Standards and Technology (NIST), is developing new matched tumor-normal samples, the first to be explicitly consented for public dissemination of genomic data and cell lines. Here, we describe a comprehensive genomic dataset from the first individual, HG008, including DNA from an adherent, epithelial-like pancreatic ductal adenocarcinoma (PDAC) tumor cell line (HG008-T) and matched normal cells from duodenal tissue (HG008-N-D) and pancreatic tissue (HG008-N-P). The data come from thirteen whole genome measurement technologies: Illumina paired-end, Element standard and long insert, Ultima UG100, PacBio (HiFi and Onso), Oxford Nanopore (standard and ultra-long), Bionano Optical Mapping, Arima and Phase Genomics Hi-C, G-banded karyotyping, directional genomic hybridization, and BioSkryb Genomics single-cell ResolveDNA. Most tumor data is from a large homogenous batch of non-viable cells after 23 passages of the primary tumor cells, along with some data from different passages to enable an initial understanding of genomic instability. These data will be used by the GIAB Consortium to develop matched tumor-normal benchmarks for somatic variant detection. In addition, extensive data from two different normal tissues from the same individual can enable understanding of mosaicism. Long reads also contain methylation tags for epigenetic analyses. We expect these data to facilitate innovation for whole genome measurement technologies, de novo assembly of tumor and normal genomes, and bioinformatic tools to identify small and structural somatic mutations. This first-of-its-kind broadly consented open-access resource will facilitate further understanding of sequencing methods used for cancer biology.","NA","biorxiv",1727302158081
"Combining evidence from human genetic and functional screens to identify pathways altering obesity and fat distribution","10.1101/2024.09.19.24313913","medrxiv",14.799999999999999,1.75,14.799999999999999,14.799999999999999,14.799999999999999,"Baya, N. A.; Sur Erdem, I.; Venkatesh, S. S.; Reibe, S.; Charles, P. D.; Navarro-Guerrero, E.; Hill, B.; Lassen, F. H.; Claussnitzer, M.; Palmer, D. S.; Lindgren, C. M.","Nikolas A Baya","Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7LF, United Kingdom; Centre for Human Genetics, Nu","2024-09-22","1","PUBLISHAHEADOFPRINT","cc_by_nc","genetic and genomic medicine","https://www.medrxiv.org/content/early/2024/09/22/2024.09.19.24313913.source.xml","Overall adiposity and body fat distribution are heritable traits associated with altered risk of cardiometabolic disease and mortality. Performing rare variant (minor allele frequency<1%) association testing using exome-sequencing data from 402,375 participants in the UK Biobank (UKB) for nine overall and tissue-specific fat distribution traits, we identified 19 genes where putatively damaging rare variation associated with at least one trait (Bonferroni-adjusted P<1.58x10-7) and 52 additional genes at FDR[&le;]1% (P[&le;]4.37x10-5). These 71 genes exhibited higher (P=3.58x10-18) common variant prioritisation scores than genes not significantly enriched for rare putatively damaging variation, with evidence of monotonic allelic series (dose-response relationships) among ultra-rare variants (minor allele count[&le;]10) in 22 genes. Five of the 71 genes have cognate protein UKB Olink data available; all five associated (P<3.80x10-6) with three or more analysed traits. Combining rare and common variation evidence, allelic series and proteomics, we selected 17 genes for CRISPR knockout in human white adipose tissue cell lines. In three previously uncharacterised target genes, knockout increased (two-sided t-test P<0.05) lipid accumulation, a cellular phenotype relevant for fat mass traits, compared to Cas9-empty negative controls: COL5A3 (fold change [FC]=1.72, P=0.0028), EXOC7 (FC=1.35, P=0.0096), and TRIP10 (FC=1.39, P=0.0157); furthermore, knockout of SLTM resulted in reduced lipid accumulation (FC=0.51, P=1.91x10-4). Integrating across population-based genetic and in vitro functional evidence, we highlight therapeutic avenues for altering obesity and body fat distribution by modulating lipid accumulation.","NA","medrxiv",1727302158081
"Monkeys Predict US Elections","10.1101/2024.09.17.613526","biorxiv",12.5,0.5,12.5,12.5,12.5,"Jiang, Y.; Huttunen, A.; Belkaya, N.; Platt, M.","Yaoguang Jiang","University of Pennsylvania","2024-09-19","1","new results","cc_by","animal behavior and cognition","https://www.biorxiv.org/content/early/2024/09/19/2024.09.17.613526.source.xml","How people vote often defies rational explanation. Physical traits sometimes sway voters more than policies do-but why? Here we show that rhesus macaques, who have no knowledge about political candidates or their policies, implicitly predict the outcomes of U.S. gubernatorial and senatorial elections based solely on visual features. Given a pair of candidate photos, monkeys spent more time looking at the loser than the winner, and this gaze bias predicted not only binary election outcomes but also the candidates vote share. Analysis of facial features revealed candidates with more masculine faces were more likely to win an election, and vote share was a linear function of jaw prominence. Our findings endorse the idea that voters spontaneously respond to evolutionarily conserved visual cues to physical prowess and that voting behavior is shaped, in part, by ancestral adaptations shared with nonhuman primates.

Significance StatementWe report that monkeys and humans alike respond spontaneously to evolutionarily conserved facial masculinity cues in political candidates, and this innate sensitivity partly shapes voting behavior, highlighting the imperative for voters to overcome this ancient heuristic by becoming more informed on candidates and their policies.","NA","biorxiv",1727302158081
"ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel: Reappraisal of Genes associated with Hypertrophic Cardiomyopathy","10.1101/2024.07.29.24311195","medrxiv",18.2,0,8.899999999999999,16.849999999999998,17.7,"Hespe, S.; Waddell, A.; Asatryan, B.; Owens, E.; Thaxton, C.; Adduru, M.-l.; Anderson, K.; Brown, E.; Hoffman-Andrews, L.; Jordan, E.; Josephs, K.; Mayers, M.; Peters, S.; Stafford, F.; Bagnall, R. D.; Bronicki, L.; Callewaert, B.; Chahal, C. A.; James, C. A.; Jarinova, O.; Landstrom, A. P.; McNally, E. M.; Murray, B.; Muino-Mosquera, L.; Parikh, V. N.; Reuter, C.; Walsh, R.; Wayburn, B.; Ware, J.; Ingles, J.","Jodie Ingles","Garvan Institute of Medical Research","2024-08-01","1","PUBLISHAHEADOFPRINT","cc_by","cardiovascular medicine","https://www.medrxiv.org/content/early/2024/08/01/2024.07.29.24311195.source.xml","BackgroundHypertrophic cardiomyopathy (HCM) is an inherited cardiac condition affecting [~]1 in 500 and exhibits marked genetic heterogeneity. Previously published in 2019, 57 HCM-associated genes were curated providing the first systematic evaluation of gene-disease validity. Here we report work by the ClinGen Hereditary Cardiovascular Disorders Gene Curation Expert Panel (HCVD-GCEP) to reappraise the clinical validity of previously curated and new putative HCM genes.

MethodsThe ClinGen systematic gene curation framework was used to re-classify the gene-disease relationships for HCM and related syndromic entities involving left ventricular hypertrophy. Genes previously curated were included if their classification was not definitive, and if the time since curation was >2-3 years. New genes with literature assertions for HCM were included for initial evaluation. Existing genes were curated for new inheritance patterns where evidence existed. Curations were presented on twice monthly calls, with the HCVD-GCEP composed of 29 individuals from 21 institutions across 6 countries.

ResultsThirty-one genes were re-curated and an additional 5 new potential HCM-associated genes were curated. Among the re-curated genes, 17 (55%) genes changed classification: 1 limited and 4 disputed (from no known disease relationship), 9 disputed (from limited), and 3 definitive (from moderate). Among these, 3 (10%) genes had a clinically relevant upgrade, including TNNC1, a 9th sarcomere gene with definitive HCM association. With new evidence, two genes were curated for multiple inheritance patterns (TRIM63, disputed for autosomal dominant but moderate for autosomal recessive; ALPK3, strong for autosomal dominant and definitive for recessive). CSRP3 was curated for a semi-dominant mode of inheritance (definitive). Nine (29%) genes were downgraded to disputed, further discouraging clinical reporting of variants in these genes. Five genes recently reported to cause HCM were curated: RPS6KB1 and RBM20 (limited), KLHL24 and MT-TI (moderate), and FHOD3 (definitive).

ConclusionsWe report 29 genes with definitive, strong or moderate evidence of causation for HCM or isolated LVH, including sarcomere, sarcomere-associated and syndromic conditions.","NA","medrxiv",1727302158081
"Axolotl epigenetic clocks offer insights into the nature of negligible senescence","10.1101/2024.09.09.611397","biorxiv",19.608,0,7,19.608,19.608,"Haluza, Y.; Zoller, J. A.; Lu, A. T.; Walters, H. E.; Lachnit, M.; Lowe, R.; Haghani, A.; Brooke, R. T.; Park, N.; Yun, M. H.; Horvath, S.","Maximina H Yun","Technische Universitat Dresden, Center for Regenerative Therapies Dresden (CRTD), Dresden, Germany","2024-09-10","1","new results","cc_no","developmental biology","https://www.biorxiv.org/content/early/2024/09/10/2024.09.09.611397.source.xml","Renowned for their regenerative abilities, axolotls also exhibit exceptional longevity, resistance to age-related diseases and apparent lack of physiological declines through lifespan, and have thus been considered organisms of negligible senescence. Whether axolotls display epigenetic hallmarks of ageing remains unknown. Here, we probe the axolotl DNA methylome throughout lifespan and present its first epigenetic clocks. Both at tissue-specific or pan-tissue levels, the clocks are biphasic, capable of predicting age during early life but not for the rest of its lifespan. We show that axolotls exhibit evolutionarily conserved features of epigenetic ageing during early life, yet their methylome is remarkably stable across lifespan, including at Polycomb Repressive Complex 2 (PRC2) target sites, suggesting that this species deviates from known patterns of epigenetic ageing. Lastly, we uncover structure-specific rejuvenation events upon regeneration. This study provides molecular insights into negligible senescence and furthers our understanding of the interplay between regeneration and ageing.","NA","biorxiv",1727302158082
"Co-circulation of Clade Ia and Ib monkeypox virus in Kinshasa Province, Democratic Republic of the Congo, July - August 2024","10.1101/2024.09.03.24312937","medrxiv",35.75,0,7,7,35.75,"Wawina-Bokalanga, T.; Akil-Bandali, P.; Kinganda Lusamaki, E.; Lokilo, E.; Jansen, D.; Amuri-Aziza, A.; Makangara-Cigolo, J.-C.; Pukuta-Simbu, E.; Ola-Mpumbe, R.; Kacita, C.; Paku-Tshambu, P.; Dantas, P.-H. L. F.; Luakanda, G.; Nkuba-Ndaye, A.; Matondo, M.; Bulabula, J.; Hasivirwe Vakaniaki, E.; O'Toole, A.; De Block, T.; Ngandu, C.; Hoff, N. A.; Low, N.; Subissi, L.; Merritt, S.; Muyembe, J.-J. T.; Liesenborghs, L.; Peeters, M.; Delaporte, E.; Kindrachuk, J.; Rimoin, A. W.; Ahuka-Mundeke, S.; Rambaut, A.; Mwamba, D.; Vercauteren, K.; Placide, M.","Tony Wawina-Bokalanga","1. Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo; 2. Service de Microbiologie, Departement de Biologie Medicale, Cliniq","2024-09-04","1","PUBLISHAHEADOFPRINT","cc_by_nc","infectious diseases","https://www.medrxiv.org/content/early/2024/09/04/2024.09.03.24312937.source.xml","Mpox cases have been reported in nearly all provinces of the Democratic Republic of the Congo as of August 2024. Monkeypox virus positive samples from Kinshasa, collected between July and mid-August 2024, were sequenced using a probe-based enrichment or optimized tiling sequencing protocol. With multiple introductions of both Clade Ia (7/12) and Ib (5/12), marking Kinshasa, and its Limete health zone specifically, as an area with co-circulation of both Clade I, a unique observation illustrating the growing complexity of Clade I mpox outbreaks in DRC.","NA","medrxiv",1727302158082
"Could the Inflation Reduction Act Maximum Fair Price Hurt Patients?","10.1101/2024.06.26.24309544","medrxiv",11.1,0,7,7,7,"Rivera, E.; Sydor, A. M.; Popovian, R.","Anne M Sydor","Global Healthy Living Foundation","2024-06-27","1","PUBLISHAHEADOFPRINT","cc_by_nd","health policy","https://www.medrxiv.org/content/early/2024/06/27/2024.06.26.24309544.source.xml","BackgroundThe Inflation Reduction Acts Medicare Drug Price Negotiation Program allows the federal government to negotiate caps for select medications. These price caps may reduce revenue for the pharmacy benefit managers (PBMs) that negotiate the actual price paid for medicines in the US. To offset the resulting pressure on their profit margins, it is possible that PBMs would, in turn, increase patients out-of-pocket costs for medicines with capped prices. The model presented here evaluates how such increased out-of-pocket costs for the anticoagulants Eliquis (apixaban) and Xarelto (rivaroxaban) could impact patients financially and clinically.

MethodsCopay distributions for all 2023 prescription fills for Eliquis and Xarelto managed by the three largest PBMs were used to approximate current copay costs. Increased out-of-pocket costs were modeled as a shift of all Eliquis and Xarelto prescriptions to the highest copay tier. The known linear relationship between copay costs and treatment abandonment was used to calculate the potential resulting increase in treatment abandonment. Known rates of morbidity and mortality due to abandoning anticoagulants were used to estimate resulting increases in morbidity and mortality.

ResultsIf the three largest PBMs all shifted costs onto patients by moving all Eliquis and Xarelto prescriptions to the highest formulary tier, Tier 6, patients copay amount would increase by $235 to $482 million for Eliquis and $105 to $206 million for Xarelto. Such an increase could lead to 169,000 to 228,000 patients abandoning Eliquis and 71,000 to 93,000 abandoning Xarelto. The resulting morbidity and mortality could include up to an additional 145,000 major cardiovascular events and up to 97,000 more deaths.

ConclusionThe Medicare Price Negotiation Program could impact patients negatively if it causes PBMs to increase patients out-of-pocket costs for medicines. Policymakers should closely monitor changes in overall affordability, including all patient out-of-pocket expenditures, for medications in the program. Preemptive measures to ensure that the most vulnerable citizens are not placed in precarious situations leading to poorer health outcomes should be considered.","NA","medrxiv",1727302158082
"Tracing SARS-CoV-2 Clusters Across Local-scales Using Genomic Data","10.1101/2024.09.18.24313896","medrxiv",5.1,0.75,5.1,5.1,5.1,"Lyu, L.; Stott, G.; Dailey, C.; Subedi, S.; Fujimoto, K.; Penn, R.; Brown, P.; Sealy, R.; Bahl, J.","Justin Bahl","University of Georgia","2024-09-22","1","PUBLISHAHEADOFPRINT","cc_no","infectious diseases","https://www.medrxiv.org/content/early/2024/09/22/2024.09.18.24313896.source.xml","Understanding local-scale transmission dynamics of SARS-CoV-2 is crucial for planning effective prevention strategies. This study analyzed over 26,000 genomes and their associated metadata collected between January and October 2021 to explore the introduction and dispersal patterns of SARS-CoV-2 in Greater Houston, a major metropolitan area noted for its demographic diversity. We identified more than a thousand independent introduction events, resulting in clusters of varying sizes, with earlier clusters presenting larger sizes and posing greater control challenges. Characterization of the sources of these introductions showed that domestic origins were more significant than international ones. Further examination of locally circulating clusters across different subregions of Greater Houston revealed varied transmission dynamics. Notably, subregions that served as primary viral sources sustained the local epidemic effectively, evidenced by: (1) a smaller proportion of new cases driven by external viral importations, and (2) longer persistence times of circulating lineages. Overall, our high-resolution spatiotemporal reconstruction of the epidemic in Greater Houston enhances understanding of the heterogeneous transmission landscape, providing key insights into regional response strategies and public health planning.

Significance StatementThe growing recognition of genome sequencing as critical for outbreak response has led to a rapid increase in the availability of sequence data. In this context, we put forward an analytical workflow within the Bayesian phylodynamic framework to identify and trace imported SARS-CoV-2 clusters using large-scale genome datasets. By utilizing metrics such as the Source-Sink Score, Local Import Score, and Persistent Time, our approach characterizes transmission patterns in each subregion and elucidates transmission heterogeneity. As new variants continue to emerge, the insights provided by our analysis are crucial for addressing the challenges of current and future pandemics effectively.","NA","medrxiv",1727302158082
"Design of an intracellular aptamer-based fluorescent biosensor to track burden in E. coli","10.1101/2024.09.23.614511","biorxiv",4.75,1.75,4.75,4.75,4.75,"Grob, A.; Copeman, T.; Chen, S. L.; Elani, Y.; Franco, E.; Ceroni, F.","Francesca Ceroni","Imperial College London","2024-09-23","1","new results","cc_by_nc_nd","synthetic biology","https://www.biorxiv.org/content/early/2024/09/23/2024.09.23.614511.source.xml","Cell burden impacts the performance of engineered synthetic systems. For this reason, there is great interest toward the development of tools to track burden and improve biotechnology applications. Fluorogenic RNA aptamers are excellent candidates for live monitoring of burden because their production is expected to impose a negligible load on transcription resources. Here we characterise the performance of a library of aptamers when expressed from different promoters in E. coli. We find that aptamer relative performance is dependent on the promoter and the strain, and that, contrary to expectation, aptamer expression impacts host fitness. By selecting two of the aptamers with brighter output and lower impact, we then design an intracellular biosensor able to report on the activation of the burden response in engineered cells. The sensor developed here adds to the collection of tools available for burden mitigation and may support bioprocessing applications where improved host performance is sought.","NA","biorxiv",1727302158082
"Empowering Refugee Voices: Using Nominal Group Technique with a Diverse Refugee Patient Advisory Committee (PAC) to Identify Health and Research Priorities","10.1101/2024.08.09.24311736","medrxiv",49.45,0,0,45,45,"Altahsh, D.; Holdbrook, L.; Norrie, E.; Sahilie, A.; Essar, M. Y.; Grewal, R.; Horbach, O.; Abdaly, F.; Santana, M.; Talavlikar, R.; Aucoin, M. W.; Coakley, A.; Fabreau, G. E.","Gabriel E. Fabreau","University of Calgary","2024-08-10","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","public and global health","https://www.medrxiv.org/content/early/2024/08/10/2024.08.09.24311736.source.xml","BackgroundDespite rising forced displacement globally, refugees health and research priorities are largely unknown. We investigated whether a diverse refugee committee could utilize participatory methods to identify health priorities and a research agenda to address them.

MethodsWe conducted a qualitative study with focus groups of current and former refugees, asylum claimants and evacuees from a specialized refugee clinic over a year. We collected sociodemographic data using standardized instruments, then utilized a four-step nominal group technique process (idea generation, recording, discussion, and voting) to identify and rank participants health and research priorities. Participants ranked their top five priorities across three time periods: Pre-migration/early arrival (0-3 months), post-migration (3 months-2 years), and long-term health (>2 years). Participants created overarching priorities and corroborated findings via a member checking step.

FindingsTwenty-three participants (median age 35 years) attended one or more of five focus groups. Twenty-one completed sociodemographic surveys: 16/21 (76%) were women, representing 8 countries of origin. Participants identified ""more family physicians"" and ""improving health system navigation"" (11/60 votes each) as top health and research priorities respectively across all resettlement periods. Participants also prioritized pre-departure healthcare system orientation and improved post-arrival and long-term mental health services. Twelve participants completed the member checking process, affirming the results with minor clarifications.

InterpretationThis proof-of-concept study illustrates how refugees can use a rigorous consensus process without external influence to prioritize their healthcare needs, direct a health research agenda to address those needs, and co-produce research. These low-cost participatory methods should be replicated elsewhere.

FundingFunded by the OBrien Institute for Public Health at the University of Calgary.","NA","medrxiv",1727302158082
"Exome wide association study for blood lipids in 1,158,017 individuals from diverse populations","10.1101/2024.09.17.24313718","medrxiv",34.650000000000006,0,0.5,34.650000000000006,34.650000000000006,"Koyama, S.; Yu, Z.; Choi, S. H.; Jurgens, S. J.; Selvaraj, M. S.; Klarin, D.; Huffman, J. E.; Clarke, S. L.; Trinh, M. N.; Ravi, A.; Dron, J. S.; Spinks, C.; Surakka, I.; Bhatnagar, A.; Lannery, K.; Hornsby, W.; Damrauer, S. M.; Chang, K.-M.; Lynch, J. A.; Assimes, T. L.; Tsao, P. S.; Rader, D. J.; Cho, K.; Peloso, G. M.; Ellinor, P. T.; Sun, Y. V.; Wilson, P. W.; The Million Veteran Program,  ; Natarajan, P.","Pradeep Natarajan","VA Boston Healthcare System, Boston, MA","2024-09-18","1","PUBLISHAHEADOFPRINT","cc_by_nc","genetic and genomic medicine","https://www.medrxiv.org/content/early/2024/09/18/2024.09.17.24313718.source.xml","Rare coding alleles play crucial roles in the molecular diagnosis of genetic diseases. However, the systemic identification of these alleles has been challenging due to their scarcity in the general population. Here, we discovered and characterized rare coding alleles contributing to genetic dyslipidemia, a principal risk for coronary artery disease, among over a million individuals combining three large contemporary genetic datasets (the Million Veteran Program, n = 634,535, UK Biobank, n = 431,178, and the All of Us Research Program, n = 92,304) totaling 1,158,017 multi-ancestral individuals. Unlike previous rare variant studies in lipids, this study included 238,243 individuals (20.6%) from non-European-like populations.

Testing 2,997,401 rare coding variants from diverse backgrounds, we identified 800 exome-wide significant associations across 209 genes including 176 predicted loss of function and 624 missense variants. Among these exome-wide associations, 130 associations were driven by non-European-like populations. Associated alleles are highly enriched in functional variant classes, showed significant additive and recessive associations, exhibited similar effects across populations, and resolved pathogenicity for variants enriched in African or South-Asian populations. Furthermore, we identified 5 lipid-related genes associated with coronary artery disease (RORC, CFAP65, GTF2E2, PLCB3, and ZNF117). Among them, RORC is a potentially novel therapeutic target through the down regulation of LDLC by its silencing.

This study provides resources and insights for understanding causal mechanisms, quantifying the expressivity of rare coding alleles, and identifying novel drug targets across diverse populations.","NA","medrxiv",1727302158082
"Rapid emergence of UV stabilizer Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate (BTMPS) in the illicit fentanyl supply across the United States in July-August 2024: Results from drug and drug paraphernalia testing","10.1101/2024.09.13.24313643","medrxiv",30.25,0,0,20.5,30.25,"Shover, C. L.; Godvin, M. E.; Appley, M.; Pyfrom, E. M.; Montero Castrillo, F.; Hochstatter, K.; Nadel, T.; Garg, N.; Koncsol, A.; Friendman, J. R.; Molina, C. A.; Romero, R.; Harshberger, B.; Spoliansky, J.; Laurel, S.; Jalayer, E.; Ruelas, J.; Gonzales, J.; Snakeoil, S.; Guerra, S.; Arellano, O.; Winstead, C.; Rybak, M.; Champney, J.; Waninger, B.; Sisco, E.","Chelsea L Shover","UCLA","2024-09-16","1","PUBLISHAHEADOFPRINT","cc_by_nc_nd","public and global health","https://www.medrxiv.org/content/early/2024/09/16/2024.09.13.24313643.source.xml","BackgroundChanges to the US drug supply historically unfold slowly with predictable patterns of geographic diffusion. Here we draw on drug checking results from around the United States to report a rapid shift in the illicit drug supply with important implications for public health. Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate, or ""BTMPS"" is a hindered amine light stabilizer with various industrial applications. Animal studies indicate multiple kinds of adverse health effects.

MethodsDrug samples collected by community-based drug checking programs in Los Angeles and Philadelphia, along with drug residue samples from other jurisdictions in California, Delaware, Maryland, and Washington, were submitted to the National Institute on Standards and Technology. Samples were qualitatively tested with Direct Analysis in Real Time mass spectrometry, with reflex to liquid chromatography mass spectrometry (LCMS) for confirmatory testing. Quantitation - percent by mass - was performed using LCMS. At both sites where drug samples were collected, participants were asked to respond to a survey that included questions about what the substance was sold as and any unexpected effects.

ResultsBetween June 1, 2024 and August 31, 2024, a total of 178 samples sold as fentanyl were tested. Of these, 43 (24%) contained BTMPS, with the proportion per month rising from 0% in June to more than a third in August. An additional 23 residue samples from sites doing residue testing contained BTMPS. Fentanyl samples with BTMPS also contained many other compounds, including local anesthetics and alpha-2 agonists. Average fentanyl purity was significantly lower in samples with BTMPS compared to samples without.

ConclusionsThe introduction of an industrial chemical to the illicit drug supply at this speed and scale is unprecedented and concerning. Further research is urgently needed to determine why it is present in the fentanyl supply and characterize effects on human health.","NA","medrxiv",1727302158082
"Glycosite Mapping and in situ Mass Spectrometry Imaging of MUC2 Glycopeptides via On-slide Digestion with Mucinase StcE","10.1101/2024.09.16.613285","biorxiv",16.15,0,0.85,16.15,16.15,"Lowery, S. C.; Tran, I. P.; Grimsley, G.; Stubler, R.; Mahoney, K. E.; Lucas, T. M.; Charkoftaki, G.; Santos-Neto, A.; Varki, N.; Vasiliou, V.; Drake, R. R.; Malaker, S. A.","Stacy A Malaker","Yale University","2024-09-20","1","new results","cc_by_nc_nd","cancer biology","https://www.biorxiv.org/content/early/2024/09/20/2024.09.16.613285.source.xml","Many cancers are characterized by altered mucin expression and glycosylation, although the mechanistic relationship between tumor glycosylation and disease progression is not well-defined. Herein, our goal was to map specific mucin glycoforms in diseased tissue, enabling correlation of the tumor glycan profile with malignant features. To this end, we developed a workflow implementing on-tissue digestion with mucinase StcE, followed by matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI) and liquid chromatography coupled to mass spectrometry (LC-MS). To optimize our workflow, we analyzed four different mucinous carcinomas derived from colon, esophageal, and salivary gland tissue.

Using this technique, we deduced the spatial distribution of StcE-generated O-glycopeptides within mucinous tumors using MALDI-IMS. Subsequent LC-MS analyses revealed the identity of different species detected in imaging experiments, in addition to comprehensively characterizing the mucinome and proteome of each tissue. Our coupled MS approach unveiled a striking mucin 2 (MUC2) expression pattern in two colorectal mucinous adenocarcinomas, in which different glycoforms clearly stratified regions within the tumor. Notably, our LC-MS experiments obtained near-complete sequence coverage over the mucin domains of MUC2, enabling glycoproteomic mapping of this canonical mucin in unprecedented depth. MUC2 glycosylation was dominated by the T and Tn antigens, with surprisingly little sialylation detected. However, O-glycans containing mono- and di-O-acetylated sialic acid were detected in low abundance. Finally, we obtained spectral evidence for an endogenous O-acetylated GalNAc, an O-glycan structure not previously reported in the literature. Overall, this proof-of-concept work underscores the potential of this technique to generate new research avenues in oncology and beyond.

Significance StatementAberrant mucin expression and glycosylation are hallmarks of cancer, but how these changes promote malignant processes are not well understood. Solid tumors are highly heterogeneous in their cellular and molecular composition, and many advanced spatial techniques have emerged in recent years to study the tumor microenvironment (TME) for better understanding disease progression. Spatially resolved glycoprotein analyses typically detect either the protein or glycan components, but not both. We developed a workflow using a dual mass spectrometry approach to map the location of intact glycopeptides in mucinous tumors, enabled by on-tissue digestion with the mucin-specific protease StcE. Future applications of this method on larger patient cohorts will enhance our understanding of glycans in malignancy, identify disease biomarkers, and define therapeutic targets.","NA","biorxiv",1727302158082
"Targeted deep brain stimulation of the motor thalamus improves speech and swallowing motor functions after cerebral lesions","10.1101/2024.09.16.24312391","medrxiv",16.249999999999996,0,0.85,15.999999999999998,16.249999999999996,"Grigsby, E. M.; Tang, L. W.; Damiani, A.; Ho, J. C.; Montanaro, I.; Nouduri, S.; Trant, S.; Constantine, T.; Adams, G. M.; Franzese, K. M.; Mahon, B. Z.; Fiez, J.; Crammond, D. J.; Stipancic, K. L.; Gonzalez-martinez, J. A.; Pirondini, E.","Elvira Pirondini","University of Pittsburgh","2024-09-16","1","PUBLISHAHEADOFPRINT","cc_no","rehabilitation medicine and physical therapy","https://www.medrxiv.org/content/early/2024/09/16/2024.09.16.24312391.source.xml","Speech and swallowing are complex motor acts that depend upon the integrity of input neural signals from motor cortical areas to control muscles of the head and neck. Lesions damaging these neural pathways result in weakness of key muscles causing dysarthria and dysphagia, leading to profound social isolation and risk of aspiration and suffocation. Here we show that Deep Brain Stimulation (DBS) of the motor thalamus improved speech and swallowing functions in two participants with dysarthria and dysphagia. First, we proved that DBS increased excitation of the face motor cortex, augmenting motor evoked potentials, and range and speed of motion of orofacial articulators in n=10 volunteers with intact neural pathways. Then, we demonstrated that this potentiation led to immediate improvement in swallowing functions in a patient with moderate dysphagia and profound dysarthria as a consequence of a traumatic brain lesion. In this subject and in another with mild dysarthria, we showed that DBS immediately ameliorated impairments of respiratory, phonatory, resonatory, and articulatory control thus resulting in a clinically significant improvement in speech intelligibility. Our data provide first-in-human evidence that DBS can be used to treat dysphagia and dysarthria in people with cerebral lesions.","NA","medrxiv",1727302158082
"Topical ABT-1 263 treatment reduces aged skin senescence and improves subsequent wound healing","10.1101/2024.08.19.608670","biorxiv",18.208,0,0,15.358,16.708,"Shvedova, M.; Thanapaul, R. J. R. S.; Ha, J.; Dhillon, J.; Shin, G. H.; Crouch, J.; Gower, A. C.; Gritli, S.; Roh, D. S.","Maria Shvedova","Boston University","2024-08-20","2","new results","cc_no","cell biology","https://www.biorxiv.org/content/early/2024/08/20/2024.08.19.608670.source.xml","Senescent cells (SnC) accumulate in aging tissues, impairing their ability to undergo repair and regeneration following injury. Previous research has demonstrated that targeting tissue senescence with senolytics can enhance tissue regeneration and repair by selectively eliminating SnCs in specific aged tissues. In this study, we focused on eliminating SnC skin cells in aged mice to assess the effects on subsequent wound healing. We applied ABT-263 directly to the skin of 24-month-old mice over a 5-day period. Following topical ABT-263, aged skin demonstrated decreased gene expression of senescent markers p16 and p21, accompanied by reductions in SA-{beta}-gal and p21-positive cells compared to DMSO controls. However, ABT-263 also triggered a temporary inflammatory response and macrophage infiltration in the skin. Bulk RNA sequencing of ABT-263-treated skin revealed prompt upregulation of genes associated with wound healing pathways, including hemostasis, inflammation, cell proliferation, angiogenesis, collagen synthesis, and extracellular matrix organization. Aged mice skin pre-treated with topical ABT-263 exhibited accelerated wound closure. In conclusion, topical ABT-263 effectively reduced several senescence markers in aged skin, thereby priming the skin for improved subsequent wound healing. This enhancement may be attributed to ABT-263-induced senolysis which in turn stimulates the expression of genes involved in extracellular matrix remodeling and wound repair pathways.","NA","biorxiv",1727302158082
"SARS-CoV-2 Survival on Skin and its Transfer from Contaminated Surfaces","10.1101/2024.09.18.613660","biorxiv",8.992,1,1,8.992,8.992,"Pitol Garcia, A. K.; Venkatesan, S.; Richards, S.; Hoptroff, M.; Majumdar, A.; Hughes, G.","Ana Karina Pitol Garcia","Liverpool School of Tropical Medicine","2024-09-19","1","new results","cc_by_nd","microbiology","https://www.biorxiv.org/content/early/2024/09/19/2024.09.18.613660.source.xml","Understanding the transmission dynamics of SARS-CoV-2, particularly its transfer from contaminated surfaces (fomites) to human skin, is crucial for mitigating the spread of COVID-19. While extensive research has examined the persistence of SARS-CoV-2 on various surfaces, there is limited understanding of how efficiently it transfers to human skin, and how long it survives on the skin. This study investigates two key aspects of SARS-CoV-2 transmission: (1) the transfer efficiency of SARS-CoV-2 from non-porous (plastic and metal) and porous (cardboard) surfaces to a 3D human skin model (LabSkin), and (2) the survival of SARS-CoV-2 on the skin under different temperature conditions. First, we validated LabSkin as a suitable surrogate for human skin by comparing the transfer efficiency of the bacteriophage Phi 6 from surfaces to LabSkin and to human volunteers fingers. No significant differences were observed, confirming LabSkins suitability for these studies. Subsequently, the transfer of SARS-CoV-2 from surfaces to LabSkin was assessed, showing that plastic and metal surfaces had similar transfer efficiencies ([~]13%), while no transfer occurred from cardboard once the inoculum had dried on the surface. Finally, the survival of SARS-CoV-2 on skin was assessed, showing a rapid decay at higher temperatures, with a half-life ranging from 2.8 to 17.8 hours depending on the temperature. These findings enhance our understanding of viral transmission via fomites and inform public health strategies to reduce the risk of SARS-CoV-2 transmission through surface contact.","NA","biorxiv",1727302158082
"""I felt shamed and blamed"": An exploration of the parental lived experience of School Distress.","10.1101/2023.02.16.23286034","medrxiv",63.50000000000004,0,0,8.399999999999999,12.599999999999998,"Mullally, S. L.; Connolly, S.","Sinad Louise Mullally","Newcastle University","2024-09-16","2","PUBLISHAHEADOFPRINT","cc_no","psychiatry and clinical psychology","https://www.medrxiv.org/content/early/2024/09/16/2023.02.16.23286034.source.xml","School Distress refers to a child or young persons (CYP) difficulty attending school due to the extreme emotional distress they experience before/during/after school. Limited research exists on the impact of School Distress on the parents/carers supporting these CYP. Using a case-control, concurrent embedded mixed-method design, we explored this lived experience. 947 parents of CYP with School Distress completed a bespoke online questionnaire, alongside two control parent groups (n=149, n=25) and one professional group (n=19).

Findings revealed a devastating impact on the mental health of parents, with parents displaying significantly heightened daily anxiety and significantly lower mood during, but not before, their childrens school attendance difficulties. In addition, parents with children experiencing School Distress reported significantly more negative emotion states and significantly fewer positive emotion states. Parents also reported overwhelmingly negative treatment from professionals, including being disbelieved or blamed for their childrens difficulties, threatened with fines and court action, and disempowered by the actions of professionals surrounding their child. Significant, deleterious impacts were also evident across all aspects of their lives, including their careers, finances, and other children. Perhaps unsurprisingly, half of these parents reported developing a new mental health condition since their childs difficulties began, with the experience itself rated as the second most threatening potential life event, superseded only by the death of a first-degree relative (including a child or spouse). On the other hand, professionals working with CYP with School Distress did not experience these deleterious mental health or wider life consequences. Despite understanding how threatening the experience is for parents, they were often quick to blame parents for their childrens difficulties. Professionals, like parents, expressed frustration with the lack of help available for these CYP and their families.

This study highlights a bleak, adversarial, and lonely picture for parents of CYP struggling to attend school. More specifically, the findings depict a system rife with parental blame; a system that appears to isolate parents through hostile, threatening, and punitive actions. A wider lack of societal understanding of the experience of School Distress further compounds this dearth of support for parents, placing parental mental health in further peril.","NA","medrxiv",1727302158082
"Trends and Influences in women authorship of randomized controlled trials in rheumatology: a comprehensive analysis of all published RCTs from 2009 to 2023","10.1101/2024.08.26.24312469","medrxiv",7,0,0,7,7,"Lauper, K.; Buitrago-Garcia, D.; Courvoisier, D. S.; Iudici, M.; Mongin, D.","Kim Lauper","Geneva University Hospitals, Division of rheumatology and Faculty of Medicine, University of Geneva, Geneva, Switzerland","2024-08-26","1","PUBLISHAHEADOFPRINT","cc_by_nc","rheumatology","https://www.medrxiv.org/content/early/2024/08/26/2024.08.26.24312469.source.xml","ObjectivesThis study aims to examine the evolution and influencing factors of womens authorship in randomized controlled trials (RCTs) published in rheumatology.

MethodsThis study included all rheumatology RCTs published from 2009 to 2023. The gender of authors was determined using forenames and countries of affiliation via the gender API service. The percentage of women in RCT publications and its association with potential factors was assessed using generalized estimating equations, considering women gender as the main binary outcome and the RCTs continent, international collaboration status, industrial funding, intervention type, sample size, journal adherence to ICMJE recommendations, impact factor, publication year, authors non-academic affiliation, and author position as covariates.

ResultsAmong the 1,092 RCTs authored by 10,794 persons, women accounted for 34.1% of authors. Woman authorship was more frequent in African-based RCTs compared to North America, when the author had a non-academic affiliation and when the last author was a woman (1.83 [1.46, 2.29], +6.1 percentage points - pp). Woman authorship was less frequent in Asian and European-based RCTs, industry-funded RCTs (OR 0.64 [0.56-0.73]; -10.3pp). Women were less often in the last (0.63 [0.54-0.74]; -10.2 pp) and second to last author position (0.73 [0.62-0.85]; -7.3pp). There were no difference looking at international status or year of publication.

ConclusionThe overall presence of women authors was 34.1%. The stagnant year-over-year representation of women in RCTs, and the lower likelihood of a woman having a position as senior author, underscores the need for more effective strategies to bridge the gender gap. RCTs with a woman last author were more likely to have a woman first author, suggesting a potential role-model effect.","NA","medrxiv",1727302158082
"Replicated blood-based biomarkers for Myalgic Encephalomyelitis not explicable by inactivity","10.1101/2024.08.26.24312606","medrxiv",282.2999999999997,0,1.35,3.45,282.2999999999997,"Beentjes, S. V.; Kaczmarczyk, J.; Cassar, A.; Samms, G. L.; Hejazi, N. S.; Khamseh, A.; Ponting, C. P.","Chris P Ponting","University of Edinburgh","2024-08-28","1","PUBLISHAHEADOFPRINT","cc_by","epidemiology","https://www.medrxiv.org/content/early/2024/08/28/2024.08.26.24312606.source.xml","Myalgic Encephalomyelitis (ME; sometimes referred to as chronic fatigue syndrome) is a relatively common and female-biased disease of unknown pathogenesis that profoundly decreases patients health-related quality-of-life. ME diagnosis is hindered by the absence of robustly-defined and specific biomarkers that are easily measured from available sources such as blood, and unaffected by ME patients low level of physical activity. Previous studies of blood biomarkers have not yielded replicated results, perhaps due to low study sample sizes (n < 100). Here, we use UK Biobank (UKB) data for up to 1,455 ME cases and 131,303 population controls to discover hundreds of molecular and cellular blood traits that differ significantly between cases and controls. Importantly, 116 of these traits are replicated, as they are significant for both female and male cohorts. Our analysis used semi-parametric efficient estimators, an initial Super Learner fit followed by a one-step correction, three types of mediators, and natural direct and indirect estimands, to decompose the average effect of ME status on molecular and cellular traits. Strikingly, these trait differences cannot be explained by ME cases restricted activity. Of 3,237 traits considered, ME status had a significant effect on only one, via the ""Duration of walk"" (UKB field 874) mediator. By contrast, ME status had a significant direct effect on 290 traits (9%). As expected, these effects became more significant with increased stringency of case and control definition. Significant female and male traits were indicative of chronic inflammation, insulin resistance and liver disease. Individually, significant effects on blood traits, however, were not sufficient to cleanly distinguish cases from controls. Nevertheless, their large number, lack of sex-bias, and strong significance, despite the  healthy volunteer selection bias of UKB participants, keep alive the future ambition of a blood-based biomarker panel for accurate ME diagnosis.","NA","medrxiv",1727302158082
"Reverse development in the ctenophore Mnemiopsis leidyi","10.1101/2024.08.09.606968","biorxiv",203.13399999999993,0,0,0,109.934,"Soto-Angel, J. J.; Burkhardt, P.","Pawel Burkhardt","Michael Sars Centre (University of Bergen)","2024-08-10","1","new results","","ecology","https://www.biorxiv.org/content/early/2024/08/10/2024.08.09.606968.source.xml","Reverse development, or the ability to rejuvenate by morphological reorganization into the preceding life cycle stage is thought to be restricted to a few species within Cnidaria. To date, the cnidarian Turritopsis dohrnii is the only known species capable of undergoing reverse development after the onset of sexual reproduction. Here, we demonstrate that the ctenophore Mnemiopsis leidyi is capable of reversal from mature lobate to early cydippid when fed following a period of stress. Our findings illuminate central aspects of ctenophore development, ecology, and evolution, and show the high potential of M. leidyi as a new model system to study reverse development and rejuvenation. Besides shedding light on the plasticity of developmental programs, our results raise fundamental questions about early animal development, body plans and life cycles.","NA","biorxiv",1727302158082
"Estimating ancestral states of complex characters: a case study on the evolution of feathers","10.1101/2024.08.23.609354","biorxiv",79.14999999999998,0,0,0,78.14999999999998,"Cockx, P.; Benton, M. J.; Keating, J. N.","Pierre Cockx","University of Bristol","2024-08-23","1","new results","cc_by","paleontology","https://www.biorxiv.org/content/early/2024/08/23/2024.08.23.609354.source.xml","Feathers are a key novelty underpinning the evolutionary success of birds, yet the origin of feathers remains poorly understood. Debates about feather evolution hinge upon whether filamentous integument has evolved once or multiple time independently on the lineage leading to modern birds. These contradictory results stem from subjective methodological differences in statistical ancestral state estimates. Here we conduct a comprehensive comparison of ancestral state estimation methodologies applied to stem-group birds, testing the role of outgroup inclusion, tree time scaling method, model choice and character coding strategy. Models are compared based on their Akaike Information Criteria (AIC), mutual information, as well as the uncertainty of marginal ancestral state estimates. Our results demonstrate that ancestral state estimates of stem-bird integument are strongly influenced by tree time scaling method, outgroup selection and model choice, while character coding strategy seems to have less effect on the ancestral estimates produced. We identify the best fitting models using AIC scores and a leave-one-out cross-validation approach (LOOCV). Our analyses broadly support the independent origin of filamentous integument in dinosaurs and pterosaurs and support a younger evolutionary origin of feathers than has been suggested previously. More generally, our study highlights that special care must be taken in selecting the outgroup, tree and model when conducting ASE analyses. With respect to model selection, our results suggest that considering a LOOCV approach, may yield more reliable results than simply comparing AIC scores when the analyses involve a limited number of taxa.","NA","biorxiv",1727302158082
"An extraordinary larval-like teleost fish from the Eocene of Bolca","10.1101/2024.08.19.608581","biorxiv",113.95000000000005,0,0,0,74.05,"Davesne, D.; Carnevale, G.","Donald Davesne","Museum National d\\\'Histoire Naturelle, Paris, France","2024-08-23","2","new results","cc_by_nc_nd","paleontology","https://www.biorxiv.org/content/early/2024/08/23/2024.08.19.608581.source.xml","""Pegasus"" volans is a highly unusual fossil teleost fish from the celebrated Eocene Bolca Lagerstatte. The fossil, known on the basis of two specimens, has been historically assigned to seamoths (Pegasidae), then to oarfish and relatives (Lampriformes). We describe its enigmatic skeletal anatomy in detail, and provide a new genus name. ""Pegasus"" volans is an extremely elongate and slender animal, with long anal and dorsal fins and a very well-developed first dorsal-fin ray reminiscent to the vexillum of some modern teleost larvae. Most striking is its extreme ventral projection of the pelvic girdle (basipterygium), associated with an element of the pectoral girdle (a long process of the coracoid) and developed pelvic-fin rays. The strongly reduced abdominal region suggests that ""Pegasus"" volans had an external gut, once again reminiscent of those of certain larval teleosts. The unique character state combination displayed by ""Pegasus"" volans make it impossible to assign it to a specific subclade within perch-like spiny-rayed fishes (Percomorpha). Nevertheless, it offers a valuable perspective on the diversity of morphologies and ecological niches occupied by teleost fishes of the early Eocene Bolca fauna.","NA","biorxiv",1727302158082
"Alzheimer's Disease clinical decision points for two plasma p-tau217 laboratory developed tests in neuropathology confirmed samples","10.1101/2024.07.27.24310872","medrxiv",55.25,0,0,0,53,"Mammel, A. E.; Hsiung, G.-Y. R.; Mousavi, A.; Hallett, K.; Mackenzie, I. R.; Hirsch-Reinshagen, V.; Biehl, D.; Gill, P.; Encarnacion, M.; Frykman, H.","Hans Frykman","BC Neuroimmunology, Neurocode USA Inc., University of British Columbia","2024-07-29","1","PUBLISHAHEADOFPRINT","cc_by_nc","neurology","https://www.medrxiv.org/content/early/2024/07/29/2024.07.27.24310872.source.xml","INTRODUCTIONWe evaluated the diagnostic performance of two commercial plasma p-tau217 immunoassays compared to CSF testing and neuropathology.

METHODS170 plasma samples from University of British Columbia Hospital Clinic for Alzheimers (AD) and Related Disorders were analyzed for p-tau217 using Fujirebio and ALZpath assays. Decision points were determined using CSF testing and autopsy findings as the standard.

RESULTSFujirebio and ALZpath p-tau217 had similar overall analytical and clinical performance, with distinct decision points for each assay. Based on autopsy finding, both p-tau217 assays identified individuals with AD from other neurodegenerative diseases (ALZpath AUC = 0.94, Fujirebio AUC= 0.90). The ALZpath assay detected AD pathology at milder disease stages compared to the Fujirebio assay.

DISCUSSIONOur study reinforces the clinical utility of plasma p-tau217 as an AD biomarker. Differences in test performance and clinical decision points suggest an assay specific diagnostic approach is required for plasma p-tau217 in clinical practice.","NA","medrxiv",1727302158082
"Glymphatic clearance is enhanced during sleep","10.1101/2024.08.24.609514","biorxiv",43.50000000000002,0.25,0.25,0.25,43.50000000000002,"Kroesbergen, E.; Riesselmann, L. V.; Gomolka, R. S.; Pla, V.; Esmail, T.; Stenmo, V. H.; Kovacs, E. R.; Nielsen, E. S.; Goldman, S. A.; Nedergaard, M.; Weikop, P.; Mori, Y.","Maiken Nedergaard","University of Copenhagen","2024-09-15","2","new results","cc_no","neuroscience","https://www.biorxiv.org/content/early/2024/09/15/2024.08.24.609514.source.xml","We here revisited the concept that glymphatic clearance is enhanced by sleep and anesthesia. Utilizing dynamic magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT), and fluorescent fiber photometry, we report brain glymphatic clearance is enhanced by both sleep and anesthesia, and sharply suppressed by wakefulness. Another key finding was that less tracer enters the brains of awake animals and that brain clearance across different brain states can only be compared after adjusting for the injected tracer dose.","NA","biorxiv",1727302158082